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ABSTRACT 
 
Management of Oral Ulcers and Oral Thrush by Community Pharmacists  
F. Amien  
MChD (Community Dentistry), Department of Community Dentistry, Faculty of 
Dentistry, University of the Western Cape. 
May 2008 
 
Oral ulcers and oral thrush could be indicative of serious illnesses such as oral 
cancer, HIV and other sexually transmitted infections (STIs), among others. There 
are many different health care workers that can be approached for advice and/or 
treatment for oral ulcers and oral thrush (sometimes referred to as mouth sores by 
patients), including pharmacists. In fact, the mild and intermittent nature of oral 
ulcers and oral thrush may most likely lead the patient to present to a pharmacist 
for immediate treatment. In addition, certain aspects of access are exempt at a 
pharmacy such as long queues and waiting times, the need to make an 
appointment and the cost for consultation. Thus pharmacies may serve as a 
reservoir of undetected cases of oral cancer, HIV and other STIs.  
Aim: To determine how community pharmacists in the Western Cape manage 
oral ulcers and oral thrush. Objectives: The data set included the prevalence of 
oral complaints confronted by pharmacists, how they manage oral ulcers, oral 
thrush and mouth sores, their knowledge about these conditions, and the influence 
of socio-economic status (SES) and metropolitan location (metro or non-metro) 
on recognition and management of the lesions. Method: A cross-sectional survey 
of community pharmacists in the Western Cape was conducted. A random sample 
of pharmacies was stratified by SES (high and low), and metropolitan location. A 
structured questionnaire was used to conduct a telephonic interview. The 
questionnaire was faxed to pharmacists 24 hours prior to the interview. 
Pharmacists were also telephoned 24 hours prior to the interview, but after the 
questionnaire was faxed, in order to gain informed consent for participation in the 
study, and to confirm a convenient time to conduct the interview. Results: Two 
thirds (63%) of pharmacists managed oral problems nearly everyday, and 30% 
managed these more than once a week. More pharmacists in high SES (73%) 
areas managed oral problems nearly everyday (Fisher Exact, p=0.0005). Just over 
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half (56%) and 49.2% of pharmacists said that ulcers and thrush, respectively, 
was the most common oral problem that they encounter. The prevalence of oral 
thrush was significantly higher in non-metro areas (58%) (RR=0.7 (0.5-1.0) Chi 
Squared=4.0, p=0.04), and it was also significantly lower in low SES areas 
(RR=1.6 (1.1-2.4), Chi Squared=6.5, p=0.01). Half the pharmacists reported that 
they would manage the patient comprehensively.  Most would take a history but 
the quality of the history is poor, thereby compromising their ability to manage 
these cases appropriately.  Only a third would refer a simple oral ulcer, thrush or 
mouth sore to a doctor/dentist but all pharmacists would have referred a long-
standing ulcer to a doctor/dentist. In terms of knowledge, only 33% of 
pharmacists were aware that oral ulcers and thrush could be indicative of HIV 
infection, and only 8% linked oral ulcers with oral cancer. There was no 
discernable pattern of management of oral ulcers and thrush, or of knowledge of 
the link between these lesions with underlying diseases, by SES and metropolitan 
locations (Chi Squared, Fisher Exact, p>0.05). Conclusion: The result of this 
study strengthens the current view of pharmacists as oral health advisors as they 
encounter oral problems regularly, most commonly oral ulcers and oral thrush. 
Therefore, the pharmacist can play an important role in the early detection of HIV 
and oral cancer.  However many pharmacists fail to refer these cases to a dentist.  
Most pharmacists lacked specific knowledge about the relationship of oral ulcers 
and thrush with underlying conditions, which may explain why many pharmacists 
are not managing these cases correctly.  There is a definite need to train 
pharmacists at both an under- and post-graduate level with specific emphasis on 
the proper management of oral ulcers, oral thrush and mouth sores, as well as 
comprehensive training that outlines why vigilant management of oral ulcers and 
oral thrush is necessary. 
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CHAPTER 1. INTRODUCTION 
 
There are many oral conditions that have a serious impact on mortality and 
quality of life of affected individuals and society at large, including caries, 
periodontal disease, head and neck trauma, sexually transmitted infections (STIs), 
and oral cancer, among others.  These are important public health problems, and 
early detection and management can prevent disability and/or death. These oral 
conditions present in a variety of ways, the nature of which will determine the 
type of help sought. There are many different health care workers (both formal 
and informal, such as traditional healers) that can be approached for advice and/or 
treatment for these conditions (Cohen and Manski, 2006), including pharmacists 
(Dickenson et al, 1995; Chestnutt et al, 1998).  
 
Some of these conditions, such as head and neck trauma, are acute and present 
with signs and symptoms that would lead the patient to seek immediate treatment 
from a medical doctor or emergency room. Therefore the pharmacist would 
probably not encounter such cases. Other conditions, such as caries and 
periodontal disease, may cause sensitivity and pain to varying degrees, ranging 
from mild intermittent toothache to severe pain that drastically affects the quality 
of life of the patient. These patients may present to one or more of a variety of 
health care professionals. Some sexually transmitted infections such as syphilis, 
gonorrhoea and HIV may present with oral lesions such as oral thrush and oral 
ulcers (Arendorf et al, 1998; Bruce and Rogers, 2004; Leão, 2006). Oral ulcers 
and oral thrush are usually self-limiting; however a non-healing ulcer could be 
indicative of oral cancer (Challacombe and Shirlaw, 1992). Generally, oral ulcers 
and oral thrush may be asymptomatic or can cause pain, discomfort, and eating 
difficulties. Oral thrush may also affect taste and/or induce a burning sensation in 
the mouth (Arendorf et al, 2000). The mild and intermittent nature of these 
symptoms,   may lead the patient to bypass other health care workers, and present 
to a pharmacist instead for immediate treatment (Dickenson et al, 1995; Chestnutt 
et al, 1998).  
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Studies have shown that pharmacists are confronted with oral problems nearly 
everyday, probably because they are easily accessible to the general public, and 
they are available throughout the working day with no need for appointments  
(Leonard et al, 1996; Gilbert, 1997). Over the years, the role of pharmacists has 
evolved from a narrow job description of drug-dispensing, to that of a health care 
professional that provides a valuable service to the community which includes 
general health advice, as well as health promotion and prevention activities 
(Lombard, 1991; Gilbert, 1998a; Beney et al, 2000). This expanded role of 
pharmacists has led to an expanded definition of pharmacists/retail pharmacists to 
‘community pharmacists’. Consequently, the term ‘community pharmacist’ will 
be used throughout the text.  The most common oral problem that community 
pharmacists encounter is oral ulcers (Dickinson et al, 1995; Gilbert, 1998b). 
Many patients also present to community pharmacists complaining of a ‘mouth 
sore’ (Gilbert, 1998a) and oral thrush (Dickinson et al, 1995). A mouth sore is a 
colloquial; non-descript term for an oral lesion that may cause pain or discomfort, 
therefore this category of oral lesions may include oral ulcers and oral thrush 
(JADA, 2002)1.   The community pharmacist has a definite role to play in both the 
recognition and the management of oral thrush and oral ulcers as they have 
important implications for the detection of serious oral diseases such as sexually 
transmitted infections (especially HIV, gonorrhoea and syphilis) and oral cancer.  
 
To date there have been not been any South African studies, and only a few 
internationally based studies to determine the pharmacists’ role in oral cancer 
detection, nor have there been any studies regarding the management of oral 
ulcers and oral thrush as an avenue for HIV prevention. A strong motivating 
factor for this study was the paucity of literature on these issues together with the 
serious consequences of sexually transmitted infections (especially HIV), and oral 
cancer. This report outlines a study that was conducted to determine how 
pharmacists manage oral ulcers, oral thrush and mouth sores in the Western Cape.  
 
 
                                                 
1 Author details of this article were not specified. This article is a column in the Journal of the American Dental 
Association, which serves as an educational pamphlet for dentists to distribute to their patients.  
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CHAPTER 2.  LITERATURE REVIEW 
 
Community pharmacists appear to have a multifaceted role when managing their 
patients and this section commences with a summary of the literature that outlines 
the role of the pharmacist as a general and oral health advisor. The importance of 
early detection of STIs and oral cancer is reviewed followed by a specific 
overview of the oral manifestations of STIs. Thereafter, the clinical 
manifestations, diagnosis and management of oral ulcers and oral thrush are 
outlined before a brief review of studies that have specifically tried to determine 
how a pharmacist would manage a potential case of oral cancer. Finally, the 
demographic factors that influence the way pharmacists’ manage their patients is 
discussed. The chapter concludes with a brief summary.  
 
2.1 The community pharmacist as a general health advisor  
Over the years, the role of the community pharmacist has expanded from being 
primarily a drug dispenser, to a health professional who is active in general health 
promotion and education (Beney et al, 2000; Lombard, 1991) with a patient-
orientated approach (Gilbert, 1998a). Ambler (1996), the president of the South 
African Association of Community Pharmacists, referred to the expanded role of 
the pharmacist as: ‘A role…..which enhances clinical skills and is vitally 
necessary, and one which should not enable him to be a barefoot doctor, but 
rather allow him to make an educated assessment of when a patient needs to be 
referred to a doctor. He needs to know what he doesn’t know. He needs to know 
where his sphere of responsibility ends and where someone else’s starts’. This 
highlights the community pharmacists’ role in the referral of patients to other 
health professionals. It also places them firmly within the Primary Health Care 
approach as they can offer preventive services that may enable them to detect 
abnormalities even before signs and symptoms of a disease manifest (Lombard, 
1991; Gilbert, 1998b). Diseases such as hypertension, diabetes mellitus, and 
kidney disease, can also be detected and appropriately referred to a doctor for 
further investigation. Such diseases can be diagnosed at an early, treatable stage 
thereby substantially reducing the risk of complications due to these diseases 
(Lombard, 1991).  
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Pharmacists have a long history as health advisors to the public (Gilbert, 1998a). 
The advice most often sought is for colds and influenza (Gilbert, 1997), infectious 
diseases, upper respiratory tract infections and urinary tract infections (Gilbert, 
1998a). It has also been shown that pharmacies tend to have a high level of 
utilization (Gilbert, 1998a). A study of 53 community pharmacies in 
Johannesburg, South Africa, demonstrated that a substantial number of patients go 
to pharmacies without a doctor’s prescription, with the intention to seek advice 
from the pharmacist (Gilbert, 1997).  
 
2.2 The community pharmacist as an oral health advisor 
Studies have also demonstrated that community pharmacists have a definitive role 
as an oral health advisor. Chestnutt and colleagues (1998) argue that community 
pharmacists and their staff are well placed to offer advice on oral health. Studies 
conducted in the United Kingdom (UK) (Dickinson et al, 1995) and in 
Johannesburg (Gilbert, 1998b) showed that community pharmacists are 
approached for advice on oral health matters on a regular basis (i.e. more than 
once a week). A study conducted in Glasgow by McGovern et al (1995) (cited in 
Chestnutt et al, 1998)1, demonstrated that oral ulcers are the most common oral 
problem that patients present with to pharmacists. Most of the pharmacists (87%) 
in the Johannesburg study (Gilbert, 1998b), and 93% of pharmacists in the UK 
study (Dickinson et al, 1995), reported that mouth ulcers are the most common 
oral complaint.  
 
Studies have already suggested that community pharmacists have a role in 
preventing the transmission of HIV (Watson et al, 2003; Ward et al, 2003). The 
presence of STIs facilitates the transmission of HIV and therefore amplifies the 
risk of HIV infection (Sangani et al, 2004; WHO, 2006), and it may be an 
indicator of HIV infection as up to 90% of new HIV infections may be 
attributable to STIs as co-factors (Robinson 1997). It is widely documented that 
many patients present to pharmacists for STI management (Garcia et al, 1998; 
Tuladhar et al, 1998; Watson et al, 2003; Ward et al, 2003; Garcia et al, 2003).  
                                                 
1 The original article by McGovern et al was unobtainable despite exhaustive efforts by the author.  
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Watson (et al, 2003) stated that: ‘There is untapped potential for community 
pharmacists to be a focus for advice and information relating to the prevention of 
HIV…’. In South Africa, Ward and colleagues (2003) demonstrated that 
pharmacists were treating STIs outside of their scope of practice and therefore 
recommended that pharmacists could be more effective in preventing HIV 
transmission if they were adequately trained and their scope of practice enhanced 
to include syndromic treatment of STIs.  Similarly, many pharmacists encounter 
oral health problems, most commonly oral ulcers (Dickinson et al, 1995; Gilbert, 
1998b), and are treating these patients with very limited training in oral health 
problems (Butler, 2006). Pharmacists are even allowed to perform HIV tests and 
provide counselling, therefore, it should not be too unrealistic to suggest that 
pharmacists have a role to play in the detection of HIV through the recognition 
and response to the presentation of oral lesions associated with this disease. 
However, the author is not aware of any studies to date that have explored this 
avenue of prevention in HIV transmission.  
 
The literature demonstrates that community pharmacists have a role in the 
treatment and referral of oral ulcers and oral thrush; however it is not expected 
that the community pharmacist should make a differential diagnosis when a 
patient presents to him/her with an ulcer. Rather, the scope of their practice is to 
realise that the presence of an oral ulcer or oral thrush could be indicative of 
systemic diseases, some of which are quite serious and warrant immediate referral 
to a dentist for proper management (Challacombe and Shirlaw, 1992, Ambler, 
1996). They must be conscious of the fact that oral lesions may not always just be 
a ‘mouth sore’ that will disappear with symptomatic treatment and without 
consequence. Therefore, the role of the pharmacist is to manage the patient 
comprehensively. This would entail taking a history, providing the correct 
symptomatic treatment as required, providing sound advice, and appropriate 
referral where necessary (Butler, 2006). In the case of oral ulcers and oral thrush, 
a proper history should include questions regarding the nature of the lesion, i.e. 
duration of the lesion; if medication has been applied; if so, was it effective, and 
whether the lesion is recurrent. These questions are important to determine if the 
lesion is of a sinister origin. Recurrent oral ulcers and oral thrush could be due to 
a sexually transmitted infection, and a single, non-healing ulcer that has been 
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present for more than two weeks could be oral cancer. The age of the affected 
person should be considered as oral cancer usually occurs in older individuals 
(Challacombe and Shirlaw, 1992; Johnson, 1999).   
 
2.3 The importance of early detection of sexually transmitted 
infections and oral cancer 
Sexually transmitted infections can have serious consequences on morbidity and 
mortality, and swift management would be beneficial to the patient therefore early 
detection is necessary.  Syphilis, chlamydia and gonorrhoea are dangerous as they 
can lead to serious complications such as congenital syphilis, pneumonia, low 
birth weight, infertility and pelvic inflammatory disease.  The latter can lead to 
abdominal pain, fever, internal abscesses, chronic pelvic pain, damage to fallopian 
tubes (leading to infertility) and ectopic pregnancy (a life-threatening condition) 
(Grodstein et al, 1993; Cunha, 1990; WHO, 2006).  Other STIs, such as HIV, are 
directly catastrophic. In addition, the presence of STIs facilitates and enhances 
HIV transmission (Sangani et al, 2004), thereby perpetuating the epidemic. 
 
HIV is highly prevalent in South Africa and is one of the greatest contributors to 
morbidity and mortality in this country. It has a devastating psychological and 
economical impact on infected and affected individuals, and has also drained state 
resources (Booysen et al, 2002). It is expensive to treat and preventable. 
Undetected cases of HIV can only fuel the already soaring epidemic as early 
detection and knowledge of one’s status may result in positive behaviour 
modification (i.e. practicing safer sex and disclosure of status to contacts) 
(Weinhardt et al, 1999). This in turn could decrease the incidence of HIV. Even 
though HIV infection is fatal and incurable, early detection would lead to patients 
taking antiretrovirals as soon as possible, thereby prolonging life and improving 
the quality of life (Cowlin, 1999; Schmidt, 1999). 
 
Oral cancer is a life threatening disease that can cause severe disfigurement and 
functional limitation thereby substantially reducing the quality of life of cancer 
patients. It also has profound psychological effects on the patient, as well their 
families and friends. Social integration is nearly impossible toward the end-stage 
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of disease, and the patient is unable to work. The treatment modalities for oral 
cancer namely surgery, radiation therapy and chemotherapy, are very expensive 
and warrant specialist management. Therefore, the cost to both the patient and the 
state is quite high. Furthermore, most cases of oral cancer can be attributed to 
certain lifestyle risk factors and are thus preventable (Johnson, 1999).  Even 
though the prevalence of oral cancer may not be that high (Hille et al, 1995), it is 
still a public health problem as it is a life-threatening disease that has an 
astounding impact on quality of life, is a great financial burden (to the state and 
patient) and can be prevented. 
 
All these diseases are serious public health problems that warrant early detection. 
The responsibility of disease detection and prevention lies with all health 
professionals, not just an elite group consisting of doctors, dentists and nurses 
(Thompson et al, 2000).  Therefore, it is important for each health professional to 
be properly trained in the detection and management of illnesses that they are 
most likely to encounter.  
 
2.4 Oral ulcers, oral thrush and sexually transmitted infections 
 Aside from having a range of other clinical symptoms, STIs such as syphilis, 
gonorrhoea and HIV commonly present with oral lesions. Oral ulcers could occur 
at any stage of syphilis, gonorrhoea and HIV (Arendorf et al, 1998; Bruce and 
Rogers, 2004; Leão, 2006). 
  
Approximately 70-90% of HIV positive patients will at some point present with 
oral lesions (Rudolph and Ogundbodede, 1999; Kamiru and Naidoo, 2002; 
Ranganathan et al, 2004). HIV can manifest in the oral cavity in many different 
forms such as, salivary gland diseases, Non Hodgkins Lymphoma, Kaposi’s 
sarcoma, ulcers, thrush, oral hairy leukoplakia, and acute necrotizing ulcerative 
gingivitis/periodontitis. The latter three are the most common HIV associated oral 
lesions in South Africa (Arendorf et al, 1999). Oral lesions may be early clinical 
features of HIV infection (Arendorf et al, 1998). In fact, oral lesions may very 
well be the first presenting sign of HIV infection (Arendorf et al, 1999), and 
therefore appropriate management of oral lesions is essential.  The most common 
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oral lesion in HIV positive patients is oral thrush (Arendorf and Holmes, 1999). 
Reported prevalence rates of oral thrush in HIV positive patients have varied 
widely, up to 72 percent in children and 94 percent in adults (Winfert et al, 1996; 
Magalhaes et al, 2001, Tirwomwe et al, 2007).  Oral ulcers are seen less 
commonly in HIV positive patients, (Scully et al, 1991) however it is the most 
common lesion that patients present to pharmacists with (Dickinson et al, 1995; 
Gilbert, 1998b; McGovern et al 1995 cited in Chestnutt et al, 1998).  The 
prevalence of oral ulcers in South African HIV positive patients is 2.9% 
(Arendorf and Holmes, 1999); however international studies have shown that the 
prevalence can range from 1-12 % (Winfert et al, 1996, Ranganathan et al, 2004; 
Tirwomwe et al, 2007).     
 
Oral ulcers and oral thrush may be symptomatic of a more sinister condition. 
Their manifestations may require comprehensive management by a dentist as 
opposed to a once-off symptomatic medication from a pharmacist, a health 
professional who may not currently be adequately trained in the manifestations of 
oral diseases. Oral ulcers and thrush can manifest in different ways, and their 
presence could be indicative of other conditions besides STIs and oral cancer. An 
outline of the manifestations of oral ulcers and oral thrush that constitute 
symptoms and adequate knowledge, with which all health professionals should be 
familiar, is presented below.  
 
2.5 Oral ulcers 
Oral ulcers are fairly prevalent oral mucosal lesions which occur in about 20% of 
the population (Woo and Sonis, 1996), and the prevalence is greater in females 
(Challacombe and Shirlaw, 1992). Ulcers typically have a yellow necrotic base, 
which is surrounded by an erythematous halo and can be painful (Woo and Sonis, 
1996) and can vary in size and number. Patients may complain of pain, 
discomfort, a burning sensation, and difficulty with eating and swallowing 
(Arendorf et al, 2000). They can appear in various parts of the oral cavity as 
single or multiple lesions. Oral ulcers are normally self-limiting by nature, and 
will usually heal in 7-14 days without treatment (Woo and Sonis, 1996). Oral 
ulcers can occur as a single episode, while other cases are recurrent. The latter is 
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usually associated with systemic disease such as blood disorders, gastrointestinal 
disorders, mucocutaneous disease, connective tissue disease, and infective disease 
(Challacombe and Shirlaw, 1992) (Refer to appendix 1 for a detailed 
classification of oral ulcers). According to the Standard Treatment Guidelines and 
Essential Drug List for South Africa (Department of Health, 2003), the 
management objectives for oral ulcers should be to reduce discomfort and 
accelerate the healing process, and should include the following: 
 
i. Drug treatment:  
• Chlorhexidine, 0.2%, 15 mL as a mouthwash, 2-4 daily for 5 days 
• Paracetemol, oral, 4-6 hourly, when required to a maximum of four  doses  
daily 
 
ii. Refer if there is: 
• Recurrent oral ulcers 
• Widespread ulcers 
 
The standard treatment guidelines (Department of Health, 2003) omitted to state 
that a long-standing oral ulcer that is resistant to treatment may be a lesion of 
neoplastic origin, and therefore would require immediate referral to a doctor or 
dentist (Challacombe and Shirlaw, 1992).  A proper history should be taken to 
ascertain if an oral ulcer has a suspicious origin (i.e. underlying systemic disease 
or neoplastic origin), and therefore should guide the pharmacist to manage such 
cases appropriately. Besides the drug treatment listed in the standard treatment 
guidelines, there is a variety of acceptable and efficacious drug management 
options available, such as (Challacombe and Shirlaw, 1992):   
• topical analgesics (e.g.  Benzocaine, Benzydamine Hydrochloride)  
• topical antimicrobial or anti-inflammatory agents (e.g. tetracycline rinse, 
Povidone oral rinse, Dequalinium hydrochloride) 
• topical corticosteroids (Triamcinilone, Hydrocortisone Sodium Succinate) 
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Severe cases can be managed with systemic corticosteroids ((Challacombe and 
Shirlaw, 1992), however these cases are best managed by a dentist or oral 
medicine specialist. 
 
2.6 Oral Thrush 
Oral thrush is a fungal infection that is most commonly caused by Candida 
albicans (Arendorf et al, 2000). There are various types of oral thrush, which 
present in different ways. It can present as a cheesy white layer which can be 
scraped off (pseudomembranous thrush), or pink or red macular lesions 
(erythematous thrush). Other types are characterized by white plaques that cannot 
be removed by scraping (hyperplastic) and by cracks/fissures at the corners of the 
mouth, which may or may not be painful (angular cheilitis) (Scully et al, 1991). 
Symptoms may range from asymptomatic to a burning sensation in the mouth. 
Patients may complain of discomfort and difficulty with swallowing (Arendorf et 
al, 2000).  
 
The underlying causes of oral thrush include antibiotic therapy, poor denture 
hygiene, xerostomia, immune deficiencies, diabetes mellitus, and some less 
common conditions (Rossie and Guggenheimer, 1997), such as congenital 
neutropenia (Rezaei et al,  2005). If left untreated, oral thrush can lead to poor 
nutrition and prolonged recovery. In extreme cases, it can be fatal when it 
becomes disseminated (Akpan and Morgan, 2002).  
 
Diagnosis of oral thrush can be based on clinical observation (Navazesh and 
Lucatorto, 1993; Akpan and Morgan, 2002). According to The Standard 
Treatment Guidelines and Essential Drugs List for South Africa (Department of 
Health, 2003); the management of oral thrush should aim to identify and eliminate 
the cause, and should include the following: 
 
i. Non-drug treatment: 
 
• Improve oral hygiene 
• Avoid bottle feeding and replace with cup-feeding 
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• Avoid the use of hypochlorite to sterilise feeding bottles, if this is not 
possible, rinse bottles adequately after sterilizing 
• Ensure proper fitting dentures 
 
ii. Drug treatment: 
• Gentian violet, 0.5% aqueous solution, applied to the inside of the mouth 
three times daily, continue for 48 hours after cure 
• For infants, nystatin oral suspension, 100 000 IU/mL, 0.5 mL after each 
feed 
• For adults, antifungal lozenges (troches), oral, 1 lozenge sucked 6 hourly 
for five days. 
• In severe cases or if the above treatment fails, an imidazole1 oral gel, 
applied twice daily for 10 days should be applied 
• HIV infected patients with oral candidiasis and painful or difficult 
swallowing have oesophageal involvement and may need fluconazole 
 
iii. Refer if there is: 
a. no improvement  
b.pharyngeal spread 
c. the diagnosis is uncertain  
 
According to Gupta and colleagues (1994), gentian violet has been discontinued 
as an antifungal treatment because of the development of resistance and adverse 
side effects, such as staining of the oral mucosa. Its’ use has been replaced by 
nystatin and amphotericin B. Topical antifungal preparations are recommended as 
the first line of treatment for oral thrush. Systemic antifungal therapy is 
appropriate in patients intolerant of, or refractory to topical treatment; and those at 
high risk of developing systemic infections (Akpan and Morgan, 2002).  
  
                                                 
1 Examples of drugs belonging to this class of antifungal therapy are miconazole, clotrimazole and ketoconazole 
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HIV and oral thrush  
The most common oral manifestation in HIV positive individuals globally, and in 
South Africa is oral thrush (Arendorf and Holmes, 1999). All the various 
manifestations of oral thrush can be seen in HIV positive individuals, of which the 
pseudomembranous and erythematous varieties are most common (Arendorf et al, 
1998; Blignaut et al, 1999). 
 
Only one study that was conducted in the UK has demonstrated how often 
patients present to the community pharmacist with oral thrush. A prevalence of 
one percent was reported (Dickinson et al, 1995). While the prevalence of patients 
presenting to a pharmacist with oral thrush complaints in the UK study may 
appear to be low, its inclusion in a study of this nature can be justified in the 
Western Cape context due to the rising levels of HIV in this province 
(Department of Health, 2007). Oral thrush is the most common oral lesion in HIV 
positive patients, therefore health professionals in South Africa would encounter 
these cases more often.  In addition, other predisposing factors for oral thrush, 
such as diabetes mellitus and malnutrition (Akpan and Morgan, 2002), are also 
fairly prevalent in South Africa. It is estimated that 5.5% of the South African 
population suffer from diabetes mellitus (Bradshaw et al, 2007). The prevalence 
of malnutrition is more alarming as 11.8% of South African children under five 
years old are underweight (Nannan et al, 2007). There are no prevalence data for 
malnutrition and diabetes mellitus in the UK so a comparison with South Africa is 
not possible. However, it is highly likely that more patients have been presenting 
to pharmacists (as well other as health care professionals) with oral thrush in the 
Western Cape due to the high prevalence of  some conditions that predisposes to 
the development of oral thrush, such as HIV, diabetes mellitus and malnutrition.   
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2.7 The Community Pharmacist and Oral Cancer Detection  
Only two published studies have reported on the role of pharmacists in oral cancer 
detection (Scully et al, 1989; Leonard et al, 1996). Both studies used a patient 
simulated methodology1 whereby the interviewer pretended to be a patient 
seeking advice for a long-standing oral ulcer in an elderly family member.  The 
results showed that most pharmacists did not know how to manage these patients 
appropriately. Scully (et al, 1989) and Leonard (et al, 1996) reported that only 
10% and 33% of pharmacy staff, respectively, recommended a referral to a 
medical or dental practitioner. Leonard (et al, 1996) suggested that their findings 
indicate that ‘pharmacists need more education about oral conditions, with 
increased emphasis on clinical features.’ After all, any chronic non-healing ulcer 
present for two or more weeks must be biopsied to rule out squamous cell 
carcinoma (Mirbod and Ahing, 2000). Thus far there have not been any studies in 
South Africa to determine pharmacists’ knowledge of oral cancer detection.   
 
2.8 Factors influencing community pharmacists’ management of 
oral conditions 
There are various factors that could affect how pharmacists manage their patients, 
and conversely how patients would seek treatment. The perceived socio-economic 
status (SES) of the patient may influence how the pharmacist would manage the 
patient. Gender, area location and age of the pharmacist as well as the patient 
could also be influencing factors. The type of patient management could also be 
influenced by the number of years of experience that the pharmacist has had in 
community pharmacy (Katznellenbogen et al, 1997), and when the pharmacist 
qualified. In South Africa, the pharmacy curriculum was reoriented so that the 
focus of teaching had shifted from a drug-dispensing oriented course; to teaching 
and enabling pharmacy students to practice pharmacy with a patient-orientated 
approach. The reorientation of the pharmacy curriculum was introduced at 
different times to various universities during the early to mid-1990’s. The new 
                                                 
1 Patient simulated methodology refers to a method of data collection whereby the interviewer 
poses as a patient with a particular query. Staff whose work is being audited is unaware of the 
simulated patient’s identity (Watson et al, 2004).   
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pharmacy curriculum was implemented at the University of the Western Cape in 
1995. By 1995, pharmacists in South Africa were taught how to take a medical 
history and also to counsel the patient regarding the main complaint (Butler, 
2006).  
 
The area location of the pharmacy and SES thereof, may also influence 
pharmacists’ management of their patients. International research has shown that 
people living in relatively lower SES areas are more likely to suffer from caries, 
advanced periodontal disease, oral cancer, and HIV (Lantz et al, 2001; Hobdell et 
al, 2003, Amien et al, 2004; Tladi, 2006). This differential profile of disease 
prevalence in lower socio economic areas directly influences the type of help and 
advice sought in these areas. Rogers (et al, 1998) conducted a study in North 
West England to determine how the locational context of a pharmacy might 
influence the nature and quality of advice-giving. They reported that locality 
(designated as rural, suburban, inner city, small and large town) does indeed 
influence and shape the activities and advice-giving potential of pharmacists. 
Some of the differences in advice-giving in the different pharmacy locations 
related in part to the SES of the populations using the pharmacy, as well as the 
available amenities in the area. This particular study suggested that ‘an inverse 
care law may be operating in relation to the use of community pharmacy, with 
people in areas with the greatest health need seemingly receiving a poorer quality 
service  than those using pharmacies in more affluent areas’.  
 
2.9 Summary  
The literature has clearly demonstrated that oral cancer and HIV are serious 
public health problems that warrant early detection and management. The 
seemingly benign nature of oral ulcers and oral thrush may tempt many patients to 
seek immediate treatment from a pharmacist, rather than a doctor, dentist or other 
health professional. Pharmacists are confronted with oral problems on a regular 
basis, and the most common oral lesions that they encounter are oral ulcers and 
oral thrush. These lesions are strongly associated with HIV infection. Therefore, 
together with other health professionals, the community pharmacist is 
advantageously placed in the health care system to be another avenue of 
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prevention for HIV and oral cancer; however, there are no studies of this nature in 
the Western Cape. 
 
2.10 Aims and objectives 
 
Aim 
To determine how community pharmacists in the Western Cape manage oral 
ulcers and oral thrush 
 
 
Objectives 
1) To determine how often patients present at a community pharmacy with 
oral complaints and oral health advice 
2) To determine the prevalence of the most common oral complaints with 
which community pharmacist is confronted  
3) To determine how community pharmacists manage oral ulcers 
4) To determine how community pharmacists manage oral thrush 
5) To determine if the management of oral ulcers and oral thrush by 
community pharmacists differs between high and low socio-economic 
groups 
6) To determine if the management of oral ulcers and oral thrush by 
community pharmacists differs between metropolitan/non-metropolitan 
locations 
7) To determine the knowledge of community pharmacists with regard to 
the link between oral ulcers and oral thrush with underlying diseases 
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CHAPTER 3.  METHODOLOGY 
 
This chapter outlines the methodology of this study and commences with a 
description of the study design and sampling procedures that were used. The latter 
section outlines the stratification procedure that was used, and includes a brief 
discussion about the choice of socio-economic indicator that was applied in this 
study. This is followed by a detailed section regarding the data collection tool and 
procedures. The chapter concludes with a brief discussion of data analysis, 
limitations of the chosen methods, ethical matters pertaining to the study and 
possible avenues of research dissemination.  
 
3.1 Study design 
A cross-sectional survey was conducted with community pharmacists in the 
Western Cape Province.  
 
3.2 Sampling 
A stratified random sample of pharmacies in the Western Cape was drawn from a 
list of pharmacies that was obtained from the South African Pharmacy Council.  
All pharmacies have to be registered with the South African Pharmacy Council; 
forming a complete list of pharmacies in the Western Cape. A computerized 
random number generator was used to draw the sample. Out of the 461 
community pharmacies on the South African Pharmacy Council list of 
pharmacies, 457 pharmacies were contactable via both telephone and fax 
machine. A sample size calculation was conducted in the Statcalc function of 
EpiInfo version 6 in order to determine the minimum number of pharmacies 
required to yield statistically valid results.  The sample size calculation was based 
on the following information: significance level = 95%; population size = 457; 
expected frequency = 50%; and worst acceptable result = 40%. According to this 
input, a minimum sample size of 79 pharmacies was required; however, 162 
pharmacies were selected in order to compensate for non-responders.  
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a) Stratification 
The sample of pharmacies was stratified by the relative SES (high and low), as 
well as by metropolitan/non-metropolitan locations (metro and non-metro 
respectively) so that there would be approximately 35 pharmacies in each of the 
following categories: 
i) High socio-economic metro (pharmacies in high socio-economic metropolitan 
area) 
ii) Low socio-economic metro (pharmacies in low socio-economic metropolitan 
area) 
iii) High socio-economic non-metro (pharmacies in high socio-economic non-            
metropolitan area) 
iv) Low socio-economic non-metro (pharmacies in low socio-economic non-           
metropolitan area) 
 
The rationale for stratifying by SES and metropolitan location was to minimize 
the chances of confounding. Studies have shown that these variables could 
influence the nature and type of advice sought by patients and provided by 
community pharmacists (Cohen et al, 2006; Rogers et al, 1998). Metro and non-
metro areas were defined by the City of Cape Town’s boundaries. A metropolitan 
area refers to all areas within the Cape Town Unicity, whereas a non-metropolitan 
area refers to all areas that do not fall within the Cape Town Unicity.  
 
Socio-economic status is a relative measure as it is difficult to define an absolute 
rich and poor state. A high SES in one country may be the equivalent to a poor or 
low SES in another country. Therefore the term ‘relative SES’ is preferred when 
referring to the SES of an area and is used in this text.  For sampling purposes, the 
relative high and low SES areas were determined by the area location of the 
pharmacy, as this information was readily available from the list of pharmacies 
obtained from the South African Pharmacy Council.   
 
The designation of pharmacies serving communities with a relatively high SES 
was determined by the top 50% ranked household income levels for each area. 
The relative SES of the area in which the pharmacy is located should serve as a 
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proxy of the SES of the clientele that the pharmacy serves (Domínguez-Berjón et 
al, 2006).  
 
b) Choice of socio-economic status indicator 
According to Daly and colleagues (2002), measures of SES indicators are meant 
to provide information about an individual’s access to social and economic 
resources. In practice numerous indicators fit this description.  Various studies 
have shown that the choice of SES measure can affect health outcomes 
(Lindelow, 2004; Daly et al, 2002, Shavers, 2007, Krieger et al, 2002) therefore 
careful selection of an appropriate SES indicator is warranted. However there is 
no published literature to date that recommends any one or a few preferred SES 
indicators for the purposes of health research in the South African context. An 
international study was conducted in order to determine optimal indicators for 
SES in health research (Daly et al, 2002). These authors stated that income and 
wealth based measures of SES have a much greater explanatory power of SES as 
compared with more conventional measures of education and occupation. Shavers 
(2007) stated that the choice of SES indicator should depend largely on the 
context in which it is being used.  South African households seem to have an 
economic culture of pooling their financial resources (Case, 2001; Berzborn, 
2007).  The use of household income1 as a SES indicator is not a new concept, as 
quite a few South African studies have used household income as a SES indicator 
(Statistics South Africa, 2000; McDonald et al, 2000; Solanki et al, 2005; Bhorat 
and Sheikh, 2004; Lalloo et al, 2004). Consequently, for the purposes of this 
study, household income was the SES indicator of choice as it is an economic 
indicator, it has been successfully applied in other studies, and it is appropriate in 
the South African context.    
 
                                                 
1 Household income is the total income of all members of a household, whether related to the household or 
not (Smeeding and Weinberg, 2001), and includes the income of the householder and all persons 15-
years-old and over in the household.  
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c) Calculation of median household income 
A commercially available dataset that consisted of the average household income 
data of the Western Cape was received from a company called Eighty20 in an 
Excel sheet format. The dataset consisted of a list of each area in the Western 
Cape, with a corresponding list of income brackets. The number of households in 
each area whose household income fell within a certain income bracket was 
indicated (Table 2.1). This dataset was used to determine the weighted average 
household income of each residential area in the Western Cape. A weighted 
average income was used as average values are severely influenced by outlier 
values and therefore the average is not always an accurate measure of the true 
average of results. The weighted average calculation overcomes this limitation by 
taking into account the frequency of the calculated values (Keller and Warrack, 
2000). The median household income for all the residential areas in the Western 
Cape was calculated in order to determine whether a residential area was in a 
relatively low or high SES area.  
 
Table 2.1: Example of data format of household income 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Atlantis Frequency 
a No income 763 
b R1 - R4 800 215 
c R4 801 - R  9 600 772 
d R9 601 - R 19 200 1671 
e R19 201 - R 38 400 3011 
f R38 401 - R 76 800 2897 
g R76 801 - R153 600 1284 
h R153 601 - R307 200 258 
i R307 201 - R614 400 24 
j R614 401 - R1 228 800 13 
k R1 228 801 - R2 457 600 109 
l R2 457 601 - R5 000 000 88 
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The weighted average income was calculated by first determining the midpoint of 
each income range, and then using the SUMPRODUCT function in Excel version 
11, which is based on the following calculation (Keller and Warrack, 2000): 
 
∑ a-l   Midpoint of income range X frequency 
Sum of all frequencies 
 
The residential areas were ranked (in ascending order) according to the weighted 
average income. The median household income was then calculated based on the 
weighted average household income in each area. The median household income 
in the metro was R149 191 and in non-metro areas was R63 223. Consequently, 
all areas in the metro with a median household income of more than R149 191 
were considered a high SES area and all areas in the non-metro with a median 
household income of more than R63 223 were considered high SES (Table 2.2). 
A single median of the household income was R92 777. This amount was not 
used to stratify by SES as it only rendered pharmacies in three categories i.e. 
Metro high and low SES and non-metro low SES. This method would have 
excluded any stratification by non-metro high SES.  
 
Table 2.2 Stratification of area location of pharmacies 
 
 
 
 
 
 
 
The median household income was used to determine socio-economic status of 
the area location of the pharmacy for sampling purposes. However, the following 
three proxy measures included in the questionnaire were used to estimate the SES 
of the clientele, and this was cross-checked with the SES of the area location of 
the pharmacy.  
 
Metropolitan  
location  
Median 
income 
Income  Area and income 
level 
Metro  > R149 191  High  Metro high SES 
Metro < R149 191 Low Metro low SES 
Non-metro > R63 223 High  Non-metro high SES 
Non-metro < R63 223 Low Non-metro low  SES 
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1) Pharmacists’ perception of their clientele’s income level. This was classified in 
the questionnaire, as high or low, however some pharmacists were unable to make 
an absolute choice as they felt that they had an equal number of clientele in both 
SES categories. They therefore referred to the answer as ‘mixed/intermediate’.  
2) Pharmacists’ perception of the percentage of patients that are on medical aid. 
3) The area location of the pharmacy. 
 
3.3. Data collection and instrument design 
The data was collected with a structured questionnaire in order to minimize any 
bias from the researcher’s interpretation of the questions (Katzenellenbogen et al, 
1997). All questions were asked in the same way, with the same probes and 
clarifications. Telephonic interviews were conducted by the researcher as it was a 
quicker and more convenient method of acquiring information from a sample that 
was meant to represent the Western Cape Province.  Even though patient 
simulated methodology has been used successfully in many studies of pharmacists 
(Scully et al, 1989; Leonard et al, 1996; Watson et al, 2004; Vacca, et al, 2005; 
Watson et al, 2006; Watson et al, 2007), it suffers from the same drawback as 
personal interviews, i.e. it limits the geographical coverage of the sample.  Postal 
and electronic surveys also allow for a greater geographical coverage, however 
these methods were excluded because of reported low response rates, the latter 
being lower than the former (McMahon et al, 2003; Seguin et al, 2004; Akl et al, 
2005).  
 
In an attempt to enhance the validity of the study, two slightly different 
questionnaires were used in order to minimize the possibility of fraudulent 
responses (Butler, 2006).  One questionnaire was faxed to the pharmacist 
(henceforth referred to as the pharmacists’ questionnaire).  The other 
questionnaire was used as a data capture sheet by the researcher (henceforth 
referred to as the researcher’s questionnaire). The researcher’s questionnaire was 
more detailed as it listed a range of possible answers to questions that appeared on 
the pharmacists’ questionnaire (refer to appendix 2 and 3 for the complete 
questionnaires). For example, question 8 in the pharmacists’ questionnaire asked:  
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If a customer presents with an ulcer/s in the mouth, would you  
a) Take a history (i.e. ask more questions about it)? 
b) Recommend a treatment? 
c) Refer the patient to a doctor/dentist? 
d) All of the above? 
e) None of the above? 
f) Other, please specify        
 
The pharmacist would immediately thereafter read question 9. 
However, during the interview, if the pharmacist answered 8a, the researcher 
would then ask the pharmacist (via an open-ended question): 
 
What questions would you ask?______________________________________ 
 
If the pharmacist answered 8b, they would then be asked (via an open-ended 
question): 
 
What treatment would you recommend?_________________________________ 
 
It should be borne in mind that the researcher’s questionnaire also serves as a data 
capture sheet. So even though the researcher’s questionnaire may appear to be a 
set of close-ended questions, most questions are in fact open-ended and the 
answer options were not mentioned to the pharmacist at all. The answer options 
listed in the researcher’s questionnaire was included for the purposes of capturing 
the answers more quickly and easily.   These answer options have been included 
in the researcher’s questionnaire as it was anticipated to be a range of the most 
likely answers provided for certain questions (the answer options were based on 
results from the pilot study). A complete copy of the researcher’s questionnaire is 
available in appendix 3. As a guide to understanding which questions were asked 
by the researcher, all the questions in the researcher’s questionnaire that were 
posed to the pharmacist appear in bold, whereas all the text that is not in bold was 
not mentioned to the pharmacist (Appendix 3).  
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The questionnaire was faxed to the pharmacy 24 hours prior to the telephonic 
interview. This was done so that the pharmacist that would be interviewed could 
familiarize him/herself with the questions that were to be asked. The researcher 
also telephoned the pharmacy 24 hours prior to the interview, but after the 
questionnaire was faxed, in order to verbally obtain informed consent from the 
pharmacist to participate in the study, and also to confirm a convenient time to 
conduct the interview. This method limited the possibility of the pharmacists 
researching the correct answers before the interview.  It should also have 
eliminated the possibility of a speculative response to questions as each answer 
had to be justified by the respondent. Most of the questions were open-ended so 
as not to lead the respondent. The above-mentioned measures were implemented 
to ensure study validity. Certain measures were taken in order to increase the 
response rate (Butler, 2006). Phone calls to pharmacists during relatively busy 
periods were avoided, such as, month end period (25th- 02nd days of the month), 
Saturday mornings, 5-6pm daily, and pension day. If more than one pharmacist 
worked at a particular pharmacy, the researcher spoke to the pharmacist who was 
available at the time and set up an interview with that particular pharmacist.  
 
The questionnaire was designed to elicit how pharmacists manage oral ulcers, oral 
thrush, mouth sores and an ulcer that has been present for more than four weeks. 
Questions regarding the management of mouth sores were included as it is a 
colloquial term used primarily by patients for many oral lesions, including oral 
ulcers and oral thrush. A question regarding how pharmacists confirmed a 
diagnosis of oral ulcer or oral thrush was deliberately excluded as the question 
itself would have been leading. This type of information was recorded under the 
answer option of ‘other’, where pharmacists could mention (without a specific 
prompt) whether they would examine the oral lesion or not. The proper 
management of an oral lesion by a pharmacist would entail taking a history, 
recommending an appropriate treatment, referral to a health professional if 
necessary and providing advice for the problem. Questions relating to these 
parameters were asked for each of the four oral lesions that were investigated in 
this study.  
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Information about the pharmacists’ work-related background was also recorded. 
The amount of work experience in community pharmacy may influence how 
pharmacists manage oral problems and their knowledge thereof 
(Katzenellenbogen et al, 1997). Therefore their age and length of time (in years) 
that they were practicing in community pharmacy was recorded. The median 
number of years that pharmacists were in practice was used as an indicator of 
their experience in community pharmacy.   
 
A question pertaining to the year in which the pharmacist had qualified was also 
included, as the pharmacy curriculum in South Africa has evolved over time. 
From approximately 1995, the pharmacy curriculum was reoriented to enable the 
paradigm shift of pharmacists’ practice from a drug-dispensing approach to a 
patient-orientated approach. This implied a more comprehensive management of 
the patient that included taking a detailed history, recommending a treatment, 
counselling the patient and referring to a health professional if necessary (Butler, 
2006). All results were analyzed using a stratified analysis that controlled for 
these factors which could have confounded the outcomes.  
 
A pilot study was conducted on 10 pharmacists (5 each in metro and non-metro 
areas) in order to test the methodology, and appropriate changes were made to the 
questionnaire thereafter. The changes made were mainly in the domain of 
clarification of questions and the phrasing thereof in order to reduce subject 
variation1 and intra-observer variation2 (Katzenellenbogen and Joubert, 2007). 
This exercise assisted greatly with constructing the answer categories for the 
researcher’s questionnaire as well as to minimize intra-observer bias. The 10 
pharmacists that participated in the pilot study were excluded from the main 
study.  
                                                 
1 Subject variation occurs when similar questions do not elicit similar answers from various subjects.  
 
2 Intra-observer variation may occur if the same  interviewer uses different prompts, cues and explanations for 
the same question. 
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3.4 Data analysis 
The data was captured in Excel version 11 and analyzed using EpiInfo version 13. 
The average of the numerical data was calculated as the measure of central 
tendency, and the range and inter-quartile range (IQR), variance and standard 
deviation was determined as an indication of the measure of the spread of the 
data. Various statistical analyses were carried out. Chi Squared tests were used to 
determine if there was a significant difference between categorical variables. The 
Fisher Exact test was conducted if the numbers were insufficient to conduct Chi 
Squared tests, or if the data was not normally distributed. Analysis of variance test 
(ANOVA) was used to determine if there was a difference between means. A 
95% significance level was used, therefore all test results with a p-value less than 
0.05 was considered statistically significant. The relative risk (RR) was also 
assessed for significance. A RR = 1 indicates that there is no difference between 
the exposure and outcome. A RR more than one indicates that the exposure is a 
risk factor, whereas a RR less than one indicates a protective factor. If the 
confidence interval of the RR contained a value of one, then the RR was not 
considered statistically significant. Results were stratified by gender, age, SES, 
metropolitan location, and the number of years that pharmacists have been 
practicing in community pharmacy.   A variable was considered to be a 
confounder if the adjusted RR and crude RR differed by more than 10%.  
 
3.5 Limitations  
All research studies are bound by varying degrees of limitations, and this study is 
no different. The choice of SES may have imparted certain limitations to this 
study. This is a common problem in research as the choice of socio-economic 
indicator can have an impact on the results. Consequently very different 
conclusions can be reached about the same issue depending on the socio-
economic indicator used (Lindelow, 2004). The use of household income in this 
study may have impacted on the sampling procedure due to misclassification of 
areas into high and low SES areas. Consequently, areas that were classified as low 
SES areas may in fact have been high SES areas. The metro areas may have 
suffered more from this shortcoming. However, as SES is a relative measure, any 
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SES indicator (such as personal income, family income, etc) would have suffered 
the same fate.  
 
The methods used in this study may raise some issues regarding validity. Even 
though stringent attempts were made to ensure that community pharmacists 
answered the questions truthfully, this could never be guaranteed. It is possible 
that some participants guessed certain answers and some may have fallen prey to 
obsequiousness bias because the interviewer was a dentist. It was not always 
possible to conduct the interview 24 hours after the questionnaire was faxed to the 
pharmacist. The unpredictable patient flow in pharmacies meant that many 
pharmacists were busy at the time agreed for the interview. Many pharmacists 
were interviewed a few days later, which may have given them enough time to 
research the questions and provide the ‘correct’ answers. The extent to which they 
are actually practicing in the manner that was indicated in the interview is 
questionable, leading to a possible overestimation as to how many pharmacists are 
actually managing these patients appropriately.  
 
3.6 Ethics Statement 
This study was approved by the Ethical and Research Committee of the 
University of the Western Cape. Participants were informed about the nature of 
the study and the main aim of the study. Participants were made aware that their 
participation in this study would be on a voluntary basis, that they could enter the 
study of their own free will, and that they could withdraw at any time. These 
statements were included on the cover letter of the questionnaire and it was 
reinforced by the researcher telephonically. Thus, informed consent was obtained 
prior to the telephonic interview and noted on the researcher’s questionnaire. 
Confidentiality was ensured to protect the identities of the participants. 
Participants’ names were noted on the researcher’s questionnaire; however they 
were not included in the data set.  
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3.7 Dissemination of research 
The findings of this research will be prepared into bound copies which will be 
available in the University of the Western Cape Dental Library. The findings of 
this research will also be prepared and submitted for publication in a dental and/or 
pharmaceutical journal. The findings will also be prepared for conference 
presentations. 
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CHAPTER 4. RESULTS 
 
This section commences with a description of the sample. The results are 
presented thereafter according to the order of the objectives. The frequency and 
prevalence of oral complaints are presented, followed by how pharmacists 
manage oral ulcers, oral thrush, a long-standing oral ulcer and mouth sores. 
Thereafter, pharmacists’ knowledge of the link between oral ulcers, oral thrush 
and underlying conditions are outlined. This section concludes by examining the 
results with the various stratification parameters used in this study.  
 
4.1 Sample description  
The sample consisted of 123 community pharmacists even though 162 
pharmacists were invited to participate in this study, yielding a response rate of 
76%. The sample consisted mainly of males (67.2%).  The mean age of all 
pharmacists was 43.9 ± 10.5 years (range: 21-72 years; IQR=35–52 years; 
median=44 years). The mean age of the male pharmacists (45.8 ± 10.7 years) was 
significantly higher than the female pharmacists (40.6 ± 9.1 years) (ANOVA, 
p=0.01). Almost all the pharmacists (98%) interviewed were principle/responsible 
pharmacists, while only two pharmacists were locums. None of the participants 
were pharmacist interns. Most of the pharmacists (78%) qualified before 1995 and 
the average number of years that the pharmacists in this study have been in 
community pharmacy was 19 ± 10.5 years (range: 1-47 years; IQR=10-25). 
Therefore, 19 years was chosen as a proxy for the amount of experience that a 
pharmacist has had in community pharmacy. The more experienced pharmacists 
would be in practice for more than 19 years, and less experienced pharmacists 
would have been in practice for less than 19 years. Subsequent analysis with this 
variable did not reveal any significant results; therefore this line of investigation 
was not pursued any further in the results section.  
 
It was not possible to compare this sample with the national profile of pharmacists 
as the information was not made available by the South African Pharmacy 
Council, and the information that was supplied was inapplicable to this study.  
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For the purposes of this analysis, the SES of the clientele was determined by the 
average household income of the area location of the pharmacy in question. A 
linear regression analysis between the weighted average household income and 
the pharmacists perception of the percentage of clientele that have medical aid 
showed a strong inverse relationship between the two variables (Correlation 
coefficient=0.12; F statistic=15.8, p<0.001). Table 4.2 shows the subsequent Chi 
Squared tests for association between the proxies used for SES in this study. 
 
 Table 4.1: Chi Squared tests for association between the indicators for socio-
economic status 
 
 
 
 
 
 
 
 
 
 
These results demonstrate that pharmacists’ perception of their clientele’s income 
and their perception of the percent clientele on medical aid does not correlate with 
the SES categories based on the household income of the area. Therefore 
subsequent analysis by SES was based solely on the average household income of 
the area. Just over a third of pharmacists (38 %) perceived that the income level of 
their clientele was high, 32 % (39) perceived that it was low, while 28.9% (35) 
claimed that they served a mixed income group.  
 
There was an equal distribution of pharmacists in each category of metro high 
SES, metro low SES, non-metro high SES and non-metro low SES, i.e. 30 in 
each, as well as between metro and non-metro areas (61 and 60 pharmacists 
respectively). Overall, 65.3% (79) of pharmacies were in a low-income area (i.e. 
median household income per annum was < R92777).  However, when separate 
medians were calculated for metro and non-metro areas, i.e. R149 191 in metro, 
Variables tested for 
association 
Relative 
Risk 
p-value 
Income level and 
perception of clientele 
income 
0.7   
(0.6-0.8) 
0.0001 
Income level and 
percent clientele on 
medical aid 
1.01  
(0.84-
1.21) 
0.95 
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and R63 223 in non-metro, then there were 57 (47.1%) and 64 (52.9%) 
pharmacists in high SES and low SES areas respectively. The average household 
income was significantly more in metro areas than non-metro areas (R147 233 ± 
R79465 and R57 723 ± R13537 respectively) (p<0.01; Kruskall-Wallis). The 
average household income in terms of metro/non-metro and SES denominations 
was significantly different (Kruskall-Wallis, p<0.001) (Table 4.2). 
 
Table 4.2: Average household income in terms of metropolitan location and 
socio-economic status 
   
Metropolitan 
location & SES 
Average household income  Test 
Metro high SES  R198 850 ± R80 355 Kruskall-
Wallis 
p=0.00001 
Metro low SES R97 864 ± R34 257 
Non-metro high SES R69 345 ± R7 901 
Non-metro low SES R47 187 ± R8 153 
Metro R147 233 ± R79 465 Kruskall-
Wallis 
p=0.00001 
Non-metro R57 723 ± R13 537 
        
Profile of non-responders 
There were 39 community pharmacists who were invited to participate in this 
study but refused to do so. The reason cited by all pharmacists that did not 
participate, regardless of socio-economic status and metropolitan location, was 
that they were too busy to do a telephone interview. Almost two-thirds of the non-
responders worked in pharmacies situated in the metro areas (62.5%) and high 
SES areas (61.5%). Table 4.3 shows that pharmacists in metro high SES areas 
were more likely not to participate in this study. 
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Table 4.3 Distribution of non-responders by metropolitan location and 
income categories 
 
Area & income level Frequency Percent 
High SES metro areas 15 38.5 
Low SES metro areas 10 25.6 
High SES non-metro areas 9 23.1 
Low SES non-metro areas 5 12.8 
Total 39 100.0 
 
4.2 Frequency of oral complaints 
Almost two thirds of pharmacists were confronted with oral problems nearly 
everyday, and almost a third dealt with these more than once a week (Figure 4.1). 
The frequency with which patients presented to pharmacists with oral problems 
did not differ significantly between metropolitan location and by gender (Chi 
Squared, p>0.05). However there were some differences in terms of SES. 
Significantly more pharmacists in low SES (when compared to those in high SES) 
areas claimed that people attended pharmacies with oral problems more than once 
a week (Fisher Exact, p=0.005), whereas significantly more pharmacists in high 
SES (73%) areas claimed that patients presented to them with oral problems 
nearly everyday. 
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Figure 4.1: Frequency of oral complaints encountered by community 
pharmacists 
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A different pattern emerged when these results were combined into two 
categories, namely regular and irregular attendance (where regular attendance 
refers to pharmacists who indicated that they deal with oral problems nearly 
everyday and more than once a week; and irregular attendance refers to 
pharmacists who indicated that they deal with oral problems less than once a 
week and hardly ever). Most pharmacists (91%) dealt with oral problems 
regularly. This did not differ by any of the stratification parameters, i.e. age, SES, 
metro/non-metro location, experience, and gender (Chi Squared, Fisher Exact, 
p>0.05).  
 
The frequency with which patients presented with oral problems did not differ 
between the four area types in this study, i.e. metro high SES, metro low SES, 
non-metro high SES, non-metro low SES (ANOVA, p=0.03) 
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4.3 Prevalence of oral complaints encountered by pharmacists 
The most common oral problems encountered by pharmacists were oral ulcers 
(55.8%) and oral thrush (49.2%). The third most common oral problem 
encountered was toothache (Table 4.4). The prevalence of mouth abscesses was 
significantly higher in high socio-economic areas (24%) when compared to low 
socio-economic areas (11%) (Fisher Exact, p=0.04). The prevalence of oral thrush 
was significantly higher in non-metro areas (58%) (Relative Risk=0.7 (0.5-1.0) 
Chi Squared=4.0, p=0.04), and it was also significantly lower in low SES areas 
(Relative Risk=1.6 (1.1-2.4), Chi Squared=6.5, p=0.01). The prevalence of mouth 
sores was significantly higher in non-metro areas (16.7%) than in metro areas 
(3.3%) (Fisher Exact, p=0.01), however there was no difference in the prevalence 
of mouth sores between high and low SES areas. The prevalence of toothache 
complaints was significantly higher in the metro areas (43.3%) than non-metro 
areas (23.3%) (Relative Risk=1.9 (1.1-3.2), Chi Squared=5.4, p=0.02) (Refer to 
Appendix 4 for a detailed list of these results).  
 
Table 4.4 Reported prevalence of oral problems encountered by community 
pharmacists   
Oral problem Percent of 
Pharmacists 
Ulcers 55.8 
Thrush 49.2 
Toothache 33.3 
Bleeding gums 19.2 
Abscess 17.5 
Other 15.8 
Sore throat 15.0 
Herpes 12.5 
Mouth sores 10.0 
Loose dentures 7.5 
Gum problems 5.8 
Pain in mouth 4.2 
Tongue problems 4.2 
 
 
 
 
 34
 
4.4 Management of oral ulcers 
Comprehensive management of oral ulcers includes taking a proper history, 
recommending an appropriate drug treatment, and referring the patient to a dentist 
or doctor if necessary. A referral should be recommended if the ulcer has been 
present for more than two weeks and/or is unresponsive to treatment.  
 
Just over half the number of pharmacists in this study (55.4%) would take a 
history, recommend a treatment and refer the patient to a health professional 
(most commonly a doctor or dentist), while a quarter (25.6%) would only take a 
history and recommend a treatment, and 9.9% would treat and refer the patient. 
One pharmacist would take a history, recommend a treatment and advise the 
patient to return to the pharmacy if the lesion has not healed with the 
recommended treatment. These results did not differ by any of the stratification 
parameters (Chi Squared, Fisher Exact, p>0.05).  
 
About a third (33%) of pharmacists would fail to refer a case of an oral ulcer to a 
health professional at all. Of those who would refer an oral ulcer; 41.6% would 
refer the patient to a doctor, 26% would refer to a dentist and 32.5% would refer 
to either a doctor or dentist (no preference indicated). Nine percent of the latter 
claimed that they would refer the patient to a dentist if the problem were ‘tooth-
related’ and to a doctor if the problem were on the mucosa. Information regarding 
the location of the lesion was elicited through history-taking. More female 
pharmacists (69.2%) than male (50%) would manage the patient 
comprehensively, i.e. take a history, recommend a treatment and refer the patient 
(Relative Risk=0.7 (0.5-0.97), Chi Squared=3.9, p=0.047). This difference was 
close to statistical significance. Overall, 66.9% of pharmacists would refer the 
patient to a health professional either immediately or recommend that they see a 
doctor or dentist if topical medication did not help. There was no significant 
difference in referral patterns by any of the stratification parameters (Chi Squared, 
Fisher Exact, p>0.05).  
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Topical treatment for oral ulcers 
 A range of topical preparations can be used for the treatment of oral ulcers, such 
as topical analgesics, topical corticosteroids and anti-microbial preparations.  
These can be in the form of a gel, cream, lozenge or mouthwash (Challacombe 
and Shirlaw, 1992). The treatment recommended by pharmacists was considered 
appropriate if it was in accordance with the Standard Treatment Guidelines and 
Essential Drug List of South Africa (Department of Health, 2003); and if 
efficacious medicines were recommended according to the literature (as outlined 
Chapter 2:Literature Review, page 9).  
 
Almost all the pharmacists (99.1%) would recommend a topical treatment for an 
oral ulcer. Table 4.5 shows the type of treatment that is favoured for this oral 
lesion. The most popular treatment recommended was a topical steroid 
(Triamcinilone), followed by Tetracain, which is a topical anaesthetic (Gibbon, 
2000). The type of treatment recommended for oral ulcers did not differ by SES, 
gender and metropolitan location (Chi Squared, Fisher Exact; p>0.05). Pwho 
qualified after 1995 were more likely to recommend Tetracain for ulcers (59%) 
than those who qualified before 1995 (36 %) (Relative Risk= 1.6 (1.1-2.5), Chi 
Squared=4.6; p=0.03). 
 
Most pharmacists (86.4%) would recommend an appropriate treatment for oral 
ulcers, compared to 6.4% (7) who would recommend treatment that is not 
indicated for an oral ulcer, such as topical antifungal therapy. A few pharmacists 
(17.3%) did not specify the type of topical medication that they would 
recommend. These results did not differ by any of the stratification parameters 
(Chi Squared, Fisher Exact, p>0.05). 
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Table 4.5 Recommended treatments for oral ulcers according to the active 
ingredient 
Gibbon, 2000. 
 
Type of history for ulcers  
The first line of appropriate management for oral ulcers rests with taking a proper 
history (Challacombe and Shirlaw, 1992). It is especially important in order to 
exclude underlying systemic disease. History-taking should attempt to ascertain 
the overall condition of the patient. This can be done with a medical and personal 
history. A history of the lesion should include questions pertaining to the duration, 
nature and severity of the oral ulcer, as well as previous response to treatment (if 
applicable).  
 
Most pharmacists (81%) would take a history if the patient had an oral ulcer. Less 
than half the pharmacists (45%) would take a past medical history, 17.7% would 
ask about lifestyle questions, 9.1% would take a personal history, and only one 
would ask for social and professional information (Refer to Appendix 5 for a 
detailed list of the questions in each category mentioned).  With regards to the 
oral ulcer, 57.3% (55) would ask for a history of the present illness, of which 57% 
would inquire about how long the lesion was there, and only 28.3% would want to 
know if the ulcer/s is recurrent. The frequency of these questions did not differ by 
Active ingredient Pharmacological 
activity* 
Percent of 
pharmacists 
Triamcinilone Topical steroid 45.5 
Tetracaine Topical analgesic 41.3 
Salicylic acid Topical analgesic 24.2 
Not specified                   - 17.4 
Chlorhexidine Antiseptic  17.0 
Povidone Antiseptic  8.3 
Dequalinium  Antiseptic  6.6 
Natural remedies - 4.1 
Antifungals - 4.1 
Vitamin supplements - 3.3 
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metropolitan location and SES (Chi Squared, Fisher Exact, p>0.05). However, 
pharmacists in low SES areas might be more likely to take a medical history as 
this difference was close to statistical significance (Fisher Exact, p=0.05). More 
women (65.7%) would take a medical history compared to men (35%) (Relative 
Risk=0.5 (0.3-0.8); Chi Squared=8.6, p=0.03). However, more male pharmacists 
(63.5%) than females (34.3%), would take a lesion history (Relative Risk=1.8 
(1.12-3.0); Chi Squared=7.7, p=0.005). Even though pharmacists were not asked 
whether they would examine the lesion, 12.4% (15) indicated that either they 
themselves or a clinic sister would examine the ulcer. This did not differ by any of 
the stratification parameters (Fisher Exact, p>0.05). 
 
Advice for oral ulcers 
Patient counselling forms an integral part of management by a community 
pharmacist. Most pharmacists (80%) would offer advice to patients who presented 
with an oral ulcer, regardless of SES and all other stratification parameters (Chi 
Squared, Fisher Exact, p>0.05). Table 4.6 shows the type of advice that 
pharmacists would give a patient for an oral ulcer. The type of advice mostly did 
not differ by the stratification parameters (Chi Squared, Fisher Exact; p>0.05), 
except for the following: more pharmacists in high SES areas (19%) than in low 
SES areas (5.5%) would offer advice regarding medicine application (Fisher 
Exact, p=0.03). 
 
Table 4.6: Type and frequency of advice provided for oral ulcers 
Advice type Percent of 
pharmacists 
Oral hygiene advice 32 
Use multivitamin supplement 26.8 
Dietary advice 18.0 
Advice regarding application of 
medicine 
11.3 
Preventive advice 10.5 
Other 7.0 
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4.5 Management of oral thrush 
Generally, oral thrush should be managed by taking a history in order to 
determine the cause and severity of the condition, provide appropriate drug and 
non-drug management, and referral if necessary (Akpan and Morgan, 2002; 
Department of Health, 2003). Pharmacists are not expected to refer all cases of 
oral thrush immediately, but should advise the patient to see a doctor/dentist if the 
thrush is recurrent and/or is unresponsive to treatment. Clinicians should perform 
an oral examination to ensure proper diagnosis, however this is not expected of 
the pharmacists in this study. Drug management includes topical therapy as a first 
line of treatment. These may include antifungal lozenges for adults, nystatin 
suspension for babies and imidazole preparations for severe cases (Department of 
Health, 2003). Non-drug management would be to provide advice that stipulates 
an improvement in oral hygiene, advice regarding denture hygiene and proper 
infant bottle hygiene (where applicable).  
Just over half of the pharmacists (57.5%) in this study would take a history, 
recommend a treatment and refer the patient; hence 43% would not manage these 
patients comprehensively. Almost two-thirds of pharmacists (61%) would refer 
the patient immediately or recommend a referral if the problem persists despite 
using topical medication. Just over a third of pharmacists would not refer the 
patient at all. Of those who would refer, 77% would refer a case of oral thrush to 
the doctor, while only 6.5% would refer to a dentist. A few pharmacists (13%) 
expressed no preference about who to refer to and 2.6% would advise the patient 
to return to the pharmacist if the medication did not clear the thrush. These results 
did not differ by any of the stratification parameters (Chi Squared, Fisher Exact, 
p>0.05). 
 
Topical treatment for oral thrush  
The treatment recommended by pharmacists was considered appropriate if it was 
in accordance with the Standard Treatment Guidelines and Essential Drug List of 
South Africa (Department of Health, 2003); and if efficacious medicines were 
recommended according to the literature (as outlined in Chapter 2: Literature 
Review, page 10 and 11). The first line of treatment would be topical antifungal 
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preparations. Systemic antifungals are prescribed in severe cases or to patients 
who are intolerant or refractory to topical treatment (Akpan and Morgan, 2002).   
Most pharmacists (94.2%) would recommend a treatment for oral thrush. Nystatin 
was the most popular treatment as it was recommended by 91.2% of pharmacists. 
A third (33%) would recommend Daktarin®, and a quarter (25.9%) would 
recommend a probiotic when taking antibiotics. Female pharmacists (38.5%) 
were more likely to recommend the latter than males (19.2%), (Relative Risk=0.5 
(0.3-0.9), Chi Squared=4.9, p=0.026). A quarter of the pharmacists in high SES 
areas (25.2%) would recommend Daktarin® compared to 40.3% of pharmacists in 
low SES areas (Fisher Exact, p=0.05). This difference was close to statistical 
significance. A few (14.3%) would recommend an alternative treatment, which 
mainly included topical antifungal preparations. However, other 
recommendations included Acyclovir, Dequadin®, Dynexan®, Betamed® and 
antibiotics. Except for those already mentioned, most treatment recommendations 
did not differ by SES and metropolitan location (Chi Squared, Fisher Exact, 
p>0.05). Overall, 96.4% of pharmacists would recommend an appropriate 
treatment for thrush. This did not differ by any of the stratification parameters 
(Chi Squared, Fisher Exact, p>0.05). 
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Type of history for thrush 
A thorough history is necessary to ascertain if oral thrush is due to underlying 
disease. The type of questions asked should attempt to elicit the nature, severity 
and duration of oral thrush. Overall, 81% of pharmacists would take a history for 
oral thrush. Just over two-thirds (67%) would take a past medical history, 6.5% 
would ask lifestyle questions and only one person would take a social and 
professional history. Half (54.5%) of the pharmacists  would take a history of the 
present illness, however only 23% would ask ‘how long has it been there?’, and 
only 16.8 % would ask if the lesion is recurrent. The latter was a more common 
question among males (23%) than females (5.4%)  (Relative Risk=4.3 (1.1-17.9), 
Chi Squared=5.5, p=0.02). A few pharmacists (9.9%) indicated that they would 
examine the lesion/mouth.  These results did not differ by metropolitan location, 
SES, gender, or the year in which pharmacists qualified (Chi Squared, p>0.05).  
Those who qualified after 1995 were more likely to take a personal history for 
oral thrush (19% vs. 1.3 %; Relative Risk=15.4 (1.9-125.8), Chi Squared=11.9; 
p=0.0005). Not a single pharmacist took a complete history. The most 
comprehensive history that was taken included questions about personal 
identifying details, past medical history, and a history of the present illness. This 
was done by one pharmacist only.  
 
Advice for oral thrush 
Pharmacists are expected to provide counselling pertaining to the patients’ 
complaint. Sound advice for oral thrush would include oral hygiene advice, i.e. 
information regarding good oral hygiene practices that is related to the cause of 
the oral thrush.   Most pharmacists (81.7%) would offer advice for oral thrush. 
This did not differ by any of the stratification parameters (Chi Squared, p>0.05). 
The most common advice given was preventive advice that was problem-specific 
(Table 4.7); for example, if it was a denture-related problem then the patient 
would be advised to practice good denture hygiene. There was no difference in 
the type of advice given by SES or metropolitan location (Chi Squared; Fisher 
Exact, p>0.05). Female pharmacists (20%) may be more inclined to give dietary 
advice than males (6.62%), (Relative Risk=0.3 (0.1-1.0), Chi Squared=4.9; 
p=0.046). Pharmacists who qualified before 1995 may be more likely to give oral 
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health advice if the patient presents with oral thrush (20% vs. 4.2%; Relative 
Risk=0.2 (0.03-1.5); Fisher Exact, p=0.05). 
 
Table 4.7 Type of advice provided for oral thrush 
Advice type Percent of 
pharmacists  
Preventive advice 22.4 
Advice regarding application of 
medicine 
18.4 
Oral health advice 16.3 
Take probiotics simultaneously 
with antibiotics 
15.3 
Dietary advice 11.2 
Use multivitamin supplement 
regularly 
4.1 
Other 1.1 
 
4.6 Management of potential oral cancer 
A long-standing oral ulcer that is unresponsive to treatment should be referred to 
a doctor/dentist immediately as it could be a carcinoma. All the pharmacists in 
this study (100%) reported that they would refer the patient to a doctor or dentist 
if the complaint was about an oral ulcer that has been present for more than four 
weeks.  Most pharmacists (81%) reported that they would refer the patient 
without recommending a treatment or taking a history. Many pharmacists felt that 
if they recommended a treatment it would result in the patient delaying seeing a 
doctor or dentist. Most pharmacists (68.4%) would refer the patient to a doctor, 
15.4% would refer to a dentist, while 16% would refer to either a doctor or 
dentist, and 0.9% (one pharmacist) would refer to a dentist if it were a tooth-
related problem and to a doctor if it was located on the mucosa (information 
regarding the location of the lesion was elicited through history-taking). This did 
not differ by any of the stratification parameters (Chi Squared, Fisher Exact, 
p>0.05).  
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Less than half of the pharmacists (46%) would offer advice for the problem, the 
majority of whom would stress the importance of the patient seeing a 
doctor/dentist as soon as possible (Table 4.8). About 10% of pharmacists would 
offer preventive advice, however the type of preventive advice was not specified. 
Few pharmacists (11%) would only give oral health advice; 11% (5) would only 
recommend a multivitamin supplement for the problem (Table 4.8).  
 
Table 4.8 Type of advice provided for a mouth ulcer that has been present 
for more than 4 weeks 
Advice type Percent of 
pharmacists  
Seek medical attention as soon as 
possible 
64 
Oral health advice 19 
Use multivitamin supplement 
regularly 
16  
Preventive advice 9.5 
Dietary advice 9.5 
 
Only 11 pharmacists reported that they would take a history, the majority (7) of 
whom would take a past a medical history and a history of the present illness. Of 
these, two pharmacists indicated that they would examine the lesion themselves. 
Seven pharmacists indicated that they would recommend a treatment. The type of 
treatment varied between prescribing antibiotics, multivitamins, a mouthwash or 
oral ointment. There was no difference in any of these results by gender, SES, 
metropolitan location and number of years in community pharmacy. Seventy one 
percent of pharmacists who qualified after 1995 were more likely to strongly 
recommend that the patient seeks medical attention as soon as possible if he/she 
presents with an ulcer that has been present for more than 4 weeks (Relative 
Risk=1.8 (1.1-2.9); Chi Squared= 4.0; p=0.04). 
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4.7 Management of mouth sores  
There are no standard treatment guidelines or scientifically sound research for the 
management of a mouth sore; however general patient management principles 
would be the same for oral ulcers and thrush, i.e. take a history, recommend an 
appropriate treatment and refer if necessary. There is no specific treatment for a 
mouth sore as it is a non-descript term for any oral lesion and may include a variety 
of oral lesions, therefore; treatment would depend on the cause.  A history should 
be taken in order to determine the cause of the mouth sore which should pave the 
way for appropriate management. Pharmacists should advise the patient to see a 
doctor/dentist if the mouth sore is recurrent and/or is unresponsive to treatment. 
 
In this study, half of the pharmacists interviewed would take a history, recommend 
a treatment, and refer the patient to a health professional (i.e. manage the patient 
comprehensively). Symptomatic management may include topical anaesthetic, anti-
inflammatory and/or antimicrobial preparations.  
 
Just less than a quarter (20%) of the pharmacists in this study would take a history 
and treat the lesion only, and 9.2% would treat and refer the patient to a health 
professional. Overall, 70% of pharmacists would refer the patient to a health 
professional.  These results did not differ by any of the stratification parameters 
(Chi-Squared, Fisher Exact, p>0.05). 
 
Topical treatment for mouth sores 
The majority of pharmacists who responded to this question did not specify the type 
of treatment that they would recommend because the treatment would depend on 
the cause of the mouth sore (Table 4.9). Most of the treatment specified did not 
differ by any of the stratification parameters, however, pharmacists in metropolitan 
areas were more likely not to specify a treatment for mouth sores (Fisher Exact, 
p=0.03). Pharmacists in high SES areas were more likely to recommend povidone 
for mouth sores (Fisher Exact, p=0.03). More pharmacists who qualified before 
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1995 would recommend a treatment for a mouth sore depending on the cause of the 
lesion (53% vs. 20%; Relative Risk=0.5 (0.3-1.1), Chi Squared=4.4, p=0.04). 
 
Table 4.9 Mouth sore treatment according to the active ingredient 
Gibbon, 2000. 
 
Most pharmacists (73.5%) would definitely recommend an appropriate treatment, 
i.e. an anti-inflammatory, analgesic and/or antiseptic medication. Almost a quarter 
did not specify an active ingredient or trade name, therefore it cannot be assessed 
whether the treatment would be appropriate or not. 
Active 
ingredient 
Pharmacological 
activity* 
% 
Pharmacists 
that 
recommended 
treatment 
Not specified - 21.8 
Benzydamine Topical 
analgesic 
11.9 
Chlorhexidine Antiseptic 10.9 
Povidone Antiseptic  9.9 
Triamcinilone Topical 
corticosteroid 
7.9 
Salicylic acid Topical 
analgesic 
6.9 
Antifungals             - 5.9 
Choline 
salicylate 
Topical 
analgesic 
5.9 
Tetracaine Topical 
analgesic  
5 
Dequalinium    Antiseptic  5 
Vitamin 
supplements 
- 4 
Natural 
remedies 
- 2 
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Type of history for mouth sores 
A third of pharmacists (33%) would take a medical history. Almost two-thirds 
(59%) would take a history of the present illness, however only half (52%) would 
specifically ask: ‘how long has it been there?’, and less than a quarter of 
pharmacists (21.2%) would ask if the lesion is recurrent. Those who qualified 
before 1995 were more likely to ask if a mouth sore lesion was recurrent (25% vs. 
5.3%, Relative Risk=0.2 (0.03-1.4); Fisher Exact, p=0.04). A lifestyle history was 
taken by 16.3% of pharmacists and 4.7% would take a personal history. 18.2% of 
pharmacists indicated that they would examine the lesion. These results did not 
differ by any of the stratification parameters (Chi Squared, Fisher Exact, p>0.05). 
 
Advice for mouth sores 
Just over two-thirds (66.7%) of pharmacists would offer advice for a mouth sore 
complaint (Table 4.10). A third of the pharmacists did not specify the type of 
advice that they would give, and just over a quarter would give advice depending 
on the cause of the problem. The type of advice given for mouth sores did not 
differ by gender, SES or metropolitan location (Chi Squared, p>0.05). 
Pharmacists in the metro areas (34%) were more likely to give oral health advice 
than those in the non-metro areas (13%) (Relative Risk=2.6 (1.1-6.3), Chi 
Squared=5.2, p=0.02). 
  
Table 4.10 Type of advice given for mouth sores       
  
 
 
Type of advice Percent of 
pharmacists  
No advice specified 32.1 
Depends on cause 28.8 
Oral health 22.2 
Application of 
medicine 
12.3 
Dietary advice 8.6 
Use multivitamin 
regularly 
7.4 
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4.8 Knowledge of diseases due to oral ulcers 
Most pharmacists (92.6%) were aware that oral ulcers could be an indication of an 
underlying disease. Only two pharmacists thought that oral ulcers were not 
indicative of an underlying disease, and seven (5.8%) did not know the answer to 
that question. These results did not differ by any of the stratification parameters 
(Chi Squared, p>0.05). Table 4.11 lists the conditions that pharmacists assumed to 
be associated with oral ulcers. Each category listed in the table is not mutually 
exclusive, for example, the same pharmacist may have mentioned that ulcers 
could be indicative of HIV, an immune deficiency and a sexually transmitted 
disease.  
 
Table 4.11 Pharmacists’ knowledge of diseases due to oral ulcers 
 
Disease     % Disease % 
Immune 
deficiency 
33.3 Dental problems 7.0 
HIV 28.9 Lifestyle factors 6.1 
Cannot think of 
any examples 
15.9 Diabetes Mellitus 6.0 
Vitamin  
Deficiency 
14.9 Sexually transmitted 
diseases  
5.3 
Viral infection 13.2 Contagious diseases 2.6 
Cancer 13.2 Gastric problems 2.6 
Medical 
conditions 
11.4 Tuberculosis 2.6 
Medication 11.4 Trauma 2.6 
Oral cancer 8.0  
% = percent of pharmacists 
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4.9 Knowledge of diseases due to oral thrush 
 Most of the pharmacists (94.2%) were aware that oral thrush could be indicative 
of an underlying condition. Very few pharmacists (5%) said that oral thrush is not 
indicative of an underlying condition and 0.8 % said they did not know the 
answer to the question. Table 4.12 lists the conditions that pharmacists assumed to 
be associated with oral thrush.  
                 
Table 4.12 Pharmacists’ knowledge of diseases due to oral thrush  
Disease Percent of 
pharmacists 
HIV 36.0 
Immune deficiency 21.0 
Other 15.0 
Antibiotic use 13.2 
Cancer 10.5 
Diabetes mellitus 10.5 
Cannot think of any examples 8.8 
Fungi overgrowth 7.9 
Corticosteroid use 7.0 
Certain medication and drug 
reactions 
6.1 
Systemic thrush 6.1 
Poor oral hygiene 4.4 
Vitamin & mineral deficiency 3.5 
 
These results did not differ by gender, metropolitan location or SES (Chi Squared, 
Fisher Exact, p>0.05). However,14.6% of pharmacists who qualified before 1995 
believed that oral thrush could be indicative of the patient being on certain 
medication compared to none of those who qualified after 1995 (Odds ratio and 
Relative Risk undefined, Fisher Exact, p=0.03). 
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4.10 Results by stratification parameters 
All the results were analyzed by gender, metropolitan location (i.e. metro or non-
metro areas), SES (high or low), when pharmacists qualified (before or after 
1995), and the number of years that pharmacists have been practicing in 
community pharmacy (more or less than 19 years). There was no discernable 
pattern of knowledge and management of oral ulcers, oral thrush and mouth sores 
by most of these parameters. There were significant differences by SES and 
metropolitan location. These results have been reported in section 4.1, 4.2 and 4.3.  
 
Table 4.13 Significant results by stratification parameters 
Parameter   Variable Relative Risk 
(CI) 
p 
Gender More females manage oral 
ulcers comprehensively 
0.7 
(0.5-0.97) 
0.047* 
More females recommend 
probiotics for oral thrush 
0.5 
(0.3-0.9) 
0.026 
More females give dietary 
advice for oral thrush 
0.3 
(0.1-1.0) 
0.046* 
Females more likely not to 
specify active ingredient for 
mouth sore treatment 
0.5 
(0.2-1.0) 
0.05* 
Graduation 
year 
After 1995 were more likely 
to recommend Tetracain for 
ulcers 
4.6 
(1.1-2.5) 
0.03 
*= close to statistical significance 
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CHAPTER 5. DISCUSSION 
The results of this study have yielded some important findings that will be 
discussed systematically, in the order in which the objectives are listed.  
 
5.1 Prevalence of patients attending pharmacies with oral 
problems and prevalence of most common oral problems 
encountered 
The results of this study have reinforced the idea of pharmacists as oral health 
advisors, as most pharmacists dealt with oral problems regularly, i.e. nearly 
everyday and more than once a week. More than half the pharmacists reported 
that the most common oral problem that they encountered were oral ulcers. This 
supports current literature from the UK (Dickinson et al, 1995) and Johannesburg 
(Gilbert, 1998b) that also found oral ulcers to be the most common oral problem 
that patients present to pharmacists with.   
 
About half of the pharmacists reported that they commonly encountered oral 
thrush, which is substantially higher than the 1% prevalence reported in the UK 
(Dickinson et al, 1995). This finding is not surprising as certain conditions that 
predispose to the development of oral thrush, such as diabetes mellitus, 
malnutrition, (Bradshaw et al 2007; Nannan et al, 2007) and HIV (UNAIDS, 
2006) are prevalent in South Africa1. There is no comparable data regarding the 
prevalence of diabetes mellitus and malnutrition in the UK. The prevalence of 
HIV is substantially higher in this country (UNAIDS, 2006) than in the UK 
(UNAIDS, 2008). In 2006, the prevalence of HIV in the UK was a mere 121 cases 
per 100 000 (UNAIDS, 2008) compared to 11 595 cases per 100 000 in South 
Africa (UNAIDS, 2006). Therefore oral thrush would be encountered more often 
by health professionals, including community pharmacists in South Africa. 
 
                                                 
1 There are many factors that predispose to the development of oral thrush as outlined in the literature review 
chapter, page 10. However, not all these factors have been measured or are measurable, for example, antibiotic 
usage. Therefore, diabetes, HIV and malnutrition have been used to highlight the higher prevalence of oral 
thrush in South Africa compared to the UK.  
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These findings suggest that pharmacies may serve as a reservoir of undetected 
cases of oral cancer, HIV and other STIs, because patients attend regularly with 
oral problems, the most common of which are oral ulcers and oral thrush.  
 
The third most common oral problem encountered was toothache and many 
pharmacists (17%) also encountered an abscess in the oral cavity, which usually is 
a result of advanced untreated caries. Caries is highly prevalent in South Africa, 
especially untreated caries (Van Wyk and Van Wyk, 2004), that would 
undoubtedly cause toothache at some point. It is clear that many patients are 
presenting to the pharmacist for symptomatic treatment for caries before they seek 
curative treatment from a dentist, indicating that the pharmacist could play a role 
in oral health education to prevent future occurrence of caries.  
  
These findings entrenches the position of the community pharmacist within the 
primary health care approach.  They are approached on a regular basis for oral 
health advice, especially oral ulcers and oral thrush, and can therefore play a key 
role in the early detection of HIV, other STIs and oral cancer, provided that these 
patients are managed correctly.  
 
5.2. Management of oral ulcers, oral thrush and mouth sores by 
community pharmacists 
 
As mentioned previously, the appropriate management of a patient would be to 
take a history, recommend a treatment and recommend a referral immediately or 
if the lesion does not clear with topical medication.  Just over half of the 
pharmacists interviewed would manage a patient comprehensively (i.e. take a 
history, recommend an appropriate treatment, provide sound advice and refer if 
necessary) if they simply complained of an oral ulcer, oral thrush or mouth sore. 
The majority of pharmacists would recommend an appropriate topical treatment 
for an oral ulcer or thrush, i.e. the treatment was according to standard treatment 
guidelines or efficacious treatment protocols outlined in the literature.  However, 
a more detailed analysis revealed that the quality of their overall management is 
questionable. A third of pharmacists would not recommend a referral for oral 
 
 
 
 
 51
ulcers and oral thrush, while a quarter would not do so for mouth sores.  Most 
pharmacists would take a history if a patient presented with any of these lesions, 
however, the quality of their history-taking is questionable. A large proportion of 
pharmacists would not take a medical history, or a history of the present illness 
and many pharmacists would not enquire if the lesion is recurrent or ask about the 
length of time that the lesion has been present. It is understandable that the time 
taken for history-taking could be severely curtailed if there are many patients 
waiting, however these questions are essential to determine if the lesion is of 
suspicious origin, and this kind of knowledge could pave the way for appropriate 
management.  
 
All the pharmacists in this study would have managed a potential case of oral 
cancer appropriately, i.e. they would refer the patient to a doctor or dentist. This is 
in stark contrast to studies conducted in Avon (Scully et al, 1989) and Minnesota 
(Leonard et al, 1999) where most pharmacists only recommended topical 
treatment. This could be due to the difference in patient management protocols in 
different countries. By 1995, the training of undergraduate pharmacists in South 
Africa shifted from a purely drug-dispensing role to that of holistic management 
of the patient, i.e. pharmacists are required to take a history, recommend an 
appropriate treatment, counsel and refer the patient to an appropriate health 
professional if necessary (Butler, 2006).  Regardless of when they qualified, the 
pharmacists in this study all had the correct knowledge of how to treat a long-
standing oral ulcer. This knowledge may have been gained through undergraduate 
training, continuous professional development (CPD) courses or self-study, and 
this may ultimately be a reflection of the training that our pharmacists receive at 
an under- and post-graduate level, or the extent to which pharmacists in this 
country practice what they have learnt.  The contrasting results could also be due 
to the different methodologies used. The Avon (Scully et al, 1989) and Minnesota 
(Leonard et al, 1999) studies used a patient simulated methodology, whereas this 
study employed the use of a hypothetical question to the pharmacist. The results 
of a real-life scenario would be more reliable as it provides an absolute indication 
of management. The hypothetical technique used in this study lends itself to 
obsequiousness bias, thus the validity of their response in this study should be 
viewed with caution. It is therefore recommended that future studies use patient 
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simulated methodology to determine how pharmacists in the Western Cape would 
manage a potential case of oral cancer.  
 
There is a definite difference between how pharmacists would manage a simple 
oral ulcer and a long-standing oral ulcer. All pharmacists would refer the patient 
to a health professional if they complained of an ulcer that has been present for 
four weeks, however the same vigilant referral pattern is not seen when a patient 
would complain of a simple mouth ulcer. Hence, pharmacists were not aware of 
the serious morbidity that a simple ulcer could represent and therefore would not 
take the initiative to determine if these oral lesions are suspicious. This was also 
evident by the poor quality of history-taking for oral ulcers in this study.  
 
It is expected that the number of years that any health professional has spent in 
practice would influence their manner of patient management (Katzenellenbogen 
et al, 1997). In this study pharmacists’ management of oral complaints, and 
knowledge of the link between oral ulcers and thrush with underlying conditions, 
did not differ regardless of how long they had been in community pharmacy, or 
whether they qualified before or after 1995.  It would also be reasonable to 
assume that pharmacists’ management would differ if they qualified before or 
after 1995 because they were trained differently during these periods. Regardless 
of when pharmacists qualified, their management of oral complaints, and 
knowledge of the link between oral ulcers and oral thrush with underlying 
conditions, did not differ, therefore pharmacists knowledge of oral health 
management should be strengthened at an under- and post-graduate level. 
  
It was interesting to note that more pharmacists would refer cases of oral ulcer, 
oral thrush and mouth sores to a medical doctor than to a dentist, and only a small 
percentage had no preference. Some pharmacists said that they would refer to a 
doctor if the problem was on the mucosa and to a dentist if the problem was tooth-
related. This indicates that there is still a perception among certain health 
professionals that dentists are ‘tooth specialists’ whose jurisdiction of treatment 
does not extend beyond tooth-specific problems despite the fact that dentists 
undergo intensive training to manage all oral complaints, whereas medical doctors 
receive general and much less intensive training for oral problems.  
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5.3. Management of oral lesions by socio-economic status and 
metro/non-metro location. 
Several inconsistent results occurred in this study when certain findings were 
stratified by SES and metropolitan location.  The prevalence of toothache and 
abscess in pharmacies are rather contradictory when stratified by SES and 
metropolitan location. In this study, non-metro areas should have correlated with 
low SES areas because the average weighted household income was significantly 
less in non-metro areas. Abscesses are indicative of advanced carious disease and 
are most common in low SES areas (Hobdell et al, 2003; Amien et al, 2004); 
however the results of this study contradicted the current literature as it was 
shown that pharmacists in high SES areas are more likely to encounter this 
problem (Table 5.1).   
 
Ironically, pharmacists in high SES areas were unexpectedly approached with oral 
problems more often than those in low SES areas.  A contrary result would be 
expected as people earning a lower income generally experience greater financial 
burden that is a huge deterrent in seeking healthcare from doctors, dentists and 
other health care professionals (Hobdell et al, 2003; Amien et al, 2004). It could 
be argued that some people may not be able to afford treatment at a pharmacist 
and therefore would attend the public health services instead, resulting in a low 
prevalence of reported oral problems at pharmacies in low SES areas. The extent 
to which this theory holds true is questionable as a paradoxical explanation could 
be encased in the utilization level of public oral health services in this country.  
Limited resources and inaccessibility are reasons cited for the poor utilization 
level of the oral health services in this country (Department of Health, 1998). 
Consequently, one would expect that people who are earning a lower income 
would utilize alternative health services, such as community pharmacies, to a 
greater extent as there may be fewer financial and time barriers at community 
pharmacies (Leonard et al, 1996; Gilbert, 1997).  
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Table 5.1: Frequency of oral problems by metropolitan location and  
socio-economic   status 
     
          
 
 
 
 
 
 
 
Significantly more pharmacists in low SES areas would recommend Daktarin gel 
as a topical remedy for oral thrush, even though it is one of the most expensive 
topical antifungal preparations. These pharmacists most probably serve a clientele 
that can afford this treatment even though they are situated in poorer areas. 
 
 These inconsistent findings suggest that the SES of the clientele may not 
correlate with the SES of the area of the pharmacy as has been suggested in 
another study (Domínguez-Berjón et al, 2006). People from low SES areas could 
be using pharmacies in high SES areas, and vice versa; as it is a common 
occurrence for people to attend a pharmacy that is not in their residential area. 
The dynamic movement of people across high and low SES areas could have 
blurred the socio-economic border distinction of the residential areas in this study.  
The socio-economic border indistinction could also be due to the SES indicator 
that was used in this study. However, as SES is a relative measure; the use of any 
other indicator would have been just as likely to introduce this kind of 
misclassification.   
 
Oral problem Stratification 
parameter 
Relative Risk p 
Ulcers Metro 0.7 0.04 
Thrush High SES* 1.6 0.01 
Toothache Metro 1.9 0.02 
Abscess High SES 2.2 0.05 
Mouth sores Metro 0.2 0.01 
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5.4 Knowledge of the link between oral ulcers and oral thrush 
with underlying conditions 
The majority of pharmacists were aware that oral ulcers and oral thrush could be 
indicative of an underlying condition, however their knowledge of specific 
conditions was lacking. Only about a third of pharmacists were aware that oral 
ulcers and oral thrush could be indicative of HIV infection, and only 8% were 
aware that oral ulcers could be an indication of oral cancer. This reinforces the 
notion that pharmacists are not aware of the serious consequences that a simple 
oral ulcer could represent.  In addition to this, even though all pharmacists 
reported that they would refer a long-standing oral ulcer, only a few mentioned 
that an ulcer of this nature could be due to oral cancer. This may indicate that they 
know how to manage a long-standing oral ulcer and that they are aware that it is 
an urgent matter, however they are not exactly sure why they are referring these 
cases.  
 
Aside from HIV and oral cancer, there is a wide spectrum of conditions that are 
associated with oral ulcers and oral thrush. While the full spectrum of such 
conditions was mentioned by pharmacists, very few pharmacists were aware of 
most of these conditions, for example, when pharmacists were asked to name 
conditions that are associated with oral ulcers, only 14.9% mentioned vitamin 
deficiencies, and 2.6% mentioned tuberculosis and trauma. These conditions are 
definitely associated with oral ulcers (Challacombe and Shirlaw, 1992), yet only a 
few pharmacists were aware of this. Very few pharmacists mentioned that 
antibiotic use and diabetes mellitus could be associated with oral thrush, yet there 
is a definite association between these factors (Arendorf et al, 2000).  
 
Some pharmacists did not give the correct examples of conditions that could be 
associated with oral ulcers and oral thrush.  A few (11.4%) mentioned that certain 
medical conditions are associated with oral ulcers, and 7% associated certain 
dental problems with oral ulcers. Unfortunately most of the medical and dental 
conditions mentioned were incorrect as those mentioned are not related to oral 
ulcers. For example gingivitis, tonsillitis, teething, poor oral hygiene, 
hypertension, flu/colds, alcohol intake, septicaemia, to name a few. Many of the 
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pharmacists were under the impression that acid reflux, stomach ulcers, 
hyperacidity and/or gastritis could result in oral ulcers. However, there is no 
association of such conditions with oral ulcers. There is a definite relationship 
with the presence of Helicobacter Pylori and gastric ulcers, gastritis and stomach 
cancer. Helicobacter Pylori may also be part of the normal oral flora and may 
play a role in recurrent aphthous stomatitis (Iamaroon et al, 2003; Fritscher et al 
2004; Mansour-Ghanaei et al, 2005). But there is no literature that has reported on 
a direct link between gastric ulcers and oral ulcers.  
 
There is a definite need to train pharmacists on how to manage oral ulcers, oral 
thrush and mouth sores, as well as to why the appropriate management of such 
lesions is important. There was no difference in pharmacists’ knowledge of the 
link between oral ulcers and oral thrush with underlying diseases regardless of the 
new pharmacy curriculum that was introduced in 1995, or how long they have 
been practicing in community pharmacy. Hence, it may be necessary to provide 
such training at a post-graduate level and through CPD training. This study has 
highlighted many irregularities that firmly indicate a gap between knowledge and 
practice among community pharmacists in the Western Cape. 
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CHAPTER 6. CONCLUSION 
 
This study strengthens the current view of pharmacists as oral health advisors 
since they are confronted with oral problems on a regular basis. Community 
pharmacists are therefore ideally placed to practice and enhance oral health 
prevention. This highlights their role in the primary health care approach to 
disease prevention. The most common oral problem that community pharmacists 
encounter is oral ulcers and oral thrush, respectively. Both these lesions can be 
indicative of underlying pathology, such as HIV, other STIs and oral cancer. 
Therefore, the pharmacist can play an important role in the early detection of 
these serious diseases by managing these lesions appropriately.  
 
Unfortunately, many pharmacists are not managing these lesions appropriately 
due to inadequate history-taking and lack of referral to a dentist or doctor. Many 
pharmacists would not ask the correct questions in order to determine if the oral 
lesion is of suspicious origin. About a third of pharmacists would not recommend 
a referral if the oral ulcer, thrush or mouth sore does not respond to treatment. 
This could have dire consequences if these patients are suffering from a serious 
illness such as HIV, other STIs or oral cancer. On the other hand, all pharmacists 
in this study would refer a long-standing oral ulcer immediately, which suggests 
that pharmacists recognise the urgency of such cases. However, very few 
pharmacists’ (8%) knew that an oral ulcer could be indicative of oral cancer. This 
suggests that pharmacists may not understand why urgent referral is required, or 
the nature of this study may have led to obsequiousness bias.  
 
Most pharmacists were aware that oral ulcers and oral thrush are indicative of 
underlying conditions; however, they lacked specific knowledge about the 
relationship of such lesions with these underlying conditions. Only a third of 
pharmacists were aware that oral ulcers and oral thrush could be indicative of 
HIV infection, and a small number (8%) of pharmacists mentioned that an oral 
ulcer could be indicative of oral cancer. This may explain why many community 
pharmacists are not managing oral ulcers and thrush appropriately. There was no 
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discernable pattern in the management or knowledge of the link between these 
lesions and underlying disease by SES and metropolitan location. 
 
There appears to be a definite need to train pharmacists with specific skills to 
improve their recognition, referral or management of oral ulcers, oral thrush and 
mouth sores, as well as the scientific evidence to explain the importance of these 
conditions. It is recommended that this training should be provided at under- and 
post-graduate level as well as through CPD training. Future studies to determine 
how pharmacists manage a potential case of oral cancer should incorporate a 
patient simulated methodology in order to overcome the limitation of 
obsequiousness bias inherent with interview techniques.  
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APPENDIX 1 
 
Classification of Oral Ulcers (Challacombe and Shirlaw, 1992): 
 
1) RECURRENT ULCERATIONS, this could be indicative of  
 
• Recurrent apthous stomatitis (minor; major and herpetiform) 
• Bechet’s disease  
• Erythema multiforme  
• Atypical ulcers   
 
 2) CURRENT/PERSISTENT ORAL ULCERATION (usually indicates 
underlying systemic disease), this can occur secondary to: 
 
• Haematological deficiency (vitamin B12, folate and iron) 
• Gastrointestinal enteropathy (ulcerative colitis, Chrohn’s disease, coeliac 
disease) 
• Dermatological condition (Benign Mucous Membrane Pemphigoid,    
Pemphigus,     Erosive Lichen Planus, Linear IgA disease).  
• Connective tissue disease (Systemic/discoid lupus erythematosus, Reiter’s 
syndrome. 
 
3. SINGLE EPISODE ULCERATION 
 
• Infective (viral, syphilitic, tuberculosis) 
• Traumatic (physical/mechanical, chemical) 
• Drug reaction 
 
4) SINGLE PERSISTANT ULCER 
 
• Neoplastic 
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APPENDIX 2 
QUESTIONAIRRE FOR THE PHARMACIST 
Department of Community Oral Health and 
School of Pharmacy 
University of the Western Cape 
 
 Att: The pharmacist  
Re: Study of pharmacists and oral health problems. 
 
Dear sir/madam 
 
The attached questionnaire is in aid of a study that is being conducted in 
collaboration with the Department of Community Dentistry (Dentistry faculty) 
and the School of Pharmacy at the University of the Western Cape. This study is 
being supervised by Prof. Nadine Butler (School of Pharmacy), and Prof Neil 
Myburgh (Department of Community Dentistry) and is being conducted on the 
premise that all health professionals should be working together and supporting 
each other in order to improve the health of communities.  This study in particular 
looks at the overlap between dentistry and pharmacy regarding oral health 
problems. The aim of this study is to determine how often patients present at a 
pharmacy with oral complaints and oral health advice; to determine the 
prevalence of the most common oral complaints that a pharmacist is confronted 
with and to determine how pharmacists manage certain oral health problems. The 
results of this study will be disseminated in dentistry and/or pharmacy journals, 
presented at dentistry and pharmacy conferences. The completed thesis document 
will be available in the UWC library.  
 
Please note that your answers will remain confidential. You also have the right to 
refuse to participate in this study. You are free to withdraw from the study at any 
time if you do decide to participate. If you decide to participate, please take note 
of the following: 
• The questionnaire has been included so that the pharmacist can acquaint 
him/herself with the questions that will be asked by the researcher; 
therefore it does not need to be completed by the pharmacist. 
• I will phone your pharmacy later today in order to gain permission to 
conduct a telephone interview with the pharmacist tomorrow, and also to 
set up a convenient time for the pharmacist to conduct the interview.  
• The interview should last about 7-10 minutes. 
• The questions that will be asked on the telephone will be based on the 
attached questionnaire. 
• Only pharmacists can be interviewed for the purpose of this study.  
 
Your participation will be greatly appreciated!!! 
 
Yours sincerely, 
Dr Feroza Amien 
Postgraduate student: Department of Community Dentistry 
Faculty of Dentistry, University of Western Cape 
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Ph: (021) 937 3147/937 3150, Email: 9537960@uwc.ac.za 
(Please feel free to contact me if you have any questions or queries). 
This questionnaire is for a master’s research study that is being conducted in 
collaboration with the Department of Community Dentistry (Dental Faculty) and 
the School of Pharmacy at the University of the Western Cape. This study is 
being supervised by Prof. Nadine Butler from the School of Pharmacy, and Prof 
Neil Myburgh from the Department of Community Dentistry. The main aim of 
this study is to determine how pharmacists manage certain oral health problems. 
Please note that your answers will remain confidential. Your co-operation will be 
appreciated immensely. 
Please note that this questionnaire is for your perusal only; it should NOT be 
mailed/faxed to anyone. The questionnaire has been included so that you can 
acquaint yourself with the questions. Dr Amien, from the Department of 
Community Dentistry, will telephone you tomorrow and ask these questions over 
the phone. Dr Amien will also phone you today in order to ask for your consent to 
participate in this study. If you agree to participate, then we can confirm a time 
for the telephone interview tomorrow, which can be done at the pharmacists’ 
convenience. The interview should last approximately 7-10 minutes. 
 
QUESTIONNAIRE 
 
SECTION A 
(1) Age:……………years                                              
(2) In which year did you qualify as a pharmacist? ………………. 
(3) How long have you been practicing in a retail pharmacy?......................... 
(4) Is the income level of your clientele mainly (tick the appropriate block) 
               High                        Low   
(5) What percentage of your clientele has medical aid?................% 
 
SECTION B: 
(6) How often do customers present with mouth problems? (Please tick one answer only)                
a)  Nearly every day  
b)  < once a week 
 c)  > once a week 
d)  Once a month 
e)   Hardly ever 
 
(7) What are the most common oral problems that customers present with? 
 
(8) If a customer presents with an ulcer/s in the mouth, would you (More than one option 
can be circled for this question).  
a) Take a history (i.e. ask more questions about it)? 
b) Recommend a treatment? 
c) Refer the patient? 
d) All of the above? 
e) None of the above? 
f) Other, please specify        
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 (9) Would you offer the customer any advice for the problem mentioned in question 8? 
(Please tick one answer only)              Yes             No         
       
(10) If a customer presents with oral thrush (a fungal infection in the mouth), would you 
(More than one option can be circled for this question).  
      a) Take a history (i.e. ask more questions about it)?  
      b) Recommend a treatment? 
      c) Refer the patient? 
      d) All of the above? 
      e) None of the above? 
      f) Other, please specify        
 
(11) Would you offer the customer any advice for the problem mentioned in question 10? 
(Please tick one answer only)                Yes             No               
 
 (12) If a customer complains that he/she has had a mouth ulcer for more than four weeks 
that hasn’t healed despite topical medication, would you (More than one option can be 
circled for this question).  
      a) Take a history (i.e. ask more questions about it)? 
      b) Recommend a treatment? 
      c) Refer the patient? 
      d) All of the above? 
      e) None of the above?  
      f) Other, please specify        
 
(13) Would you offer the customer any advice for the problem mentioned in question 12? 
(Please tick one answer only)                     Yes             No               
 
(14) If a customer complains of a ‘mouth sore’ would you (More than one option can be 
circled for this question).  
      a) Take a history (i.e. ask more questions about it)? 
      b) Recommend a treatment? 
      c) Refer the patient? 
      d) All of the above? 
      e) None of the above? 
      f) Other, please specify        
 
(15) Would you offer the customer any advice for the problem mentioned in question 14? 
(Please tick one answer only)                     Yes             No               
 
(16) Can ulcers in the mouth be indicative of underlying disease? 
 (Please tick one answer only)               Yes             No              I don’t know    
 
(17) Can thrush in the mouth be indicative of underlying disease/s?  
(Please tick one answer only)                 Yes             No              I don’t know    
 
THANK YOU VERY MUCH FOR YOUR PARTICIPATION! 
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APPENDIX 3 
 
Note to reader: all the questions that were posed to pharmacists appear in bold, 
whereas all text that is not in bold was not mentioned to the pharmacist. 
QUESTIONNAIRE FOR RESEARCHER 
 
Pharmacy 
council no: 
 Record Number:  
 
Consent to 
participate 
1.Y 2.N                  
Date: 
 
 
Pharmacist 
name: 
 
 
What type of pharmacist are 
you?     
1.Intern 2. locum 3. principle 
 
Area location of 
pharmacy 
 
 
Area type: 1. Metro 2. Non- metro 
                                               
Census Income level: 1. High  2.Low 
 
Area & 
income 
level 
1.  
Metro 
High  
2. 
Metro 
Low 
3. 
Non metro 
high 
4.  
Non metro 
low 
 
Ph. 
No 
(         ) Gender 1. Male 2. Female 
 
SECTION A 
 
1) Age:……………years                                      
 
2) In which year did you qualify as a pharmacist? ………………. 
 
3) How long have you been practicing in a retail pharmacy?......................... 
 
4) Is the income level of your clientele mainly (tick the appropriate block) 
  High                                           Low   
 
5) What percentage of your clientele has medical aid?...........% 
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SECTION B 
 
6) How often do customers present with mouth problems? (Please tick one answer 
only) 
 a)  1. Nearly every day  
    b)  2. < Once a week 
 c)  3. > Once a week 
 d)  4. Once a month 
 e)  5. Hardly ever 
 
 (7) What are the most common oral problems which customers present with (please 
tick the appropriate options, note: more than one option can be chosen) 
 
1) Toothache  
2) Bleeding gums  
3) Loose/broken dentures  
4) Mouth ulcers  
5) Thrush  
6) Herpes  
7) Mouth Sores  
8) Sensitive teeth  
9) Teething in kids  
10) Pain in the mouth  
11)    Other, please specify  
 
(8) If a customer presents with an ulcer/s in the mouth, would you  
a)  1. Take a history (i.e. ask more questions about it) 
b)  2. Recommend a treatment? 
c)  3. Refer the patient to a doctor/dentist? 
d)  4. All of the above? 
e)  5. a & b 
f)    6. a & c 
g)  7. b & c 
h)  8. None of the above?  
i)    9. Other, please specify        
 
 (8a) What questions would you ask? 
1. How long has it been there? 
2. What medication have you used for the ulcer? 
3. What medication have you taken recently?  
4. Is it a recurring problem? 
5. Is it painful? 
6. Other, please specify __________________________________________ 
 
(8b) What treatment would you recommend? 
1. Kenalog in orabase 
2. Pyralvex 
3. Dynexan 
4. Chlorhexidine 
5.Other ________________________________________________________ 
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(8c) Who would you refer the patient to: 1. dentist     2. doctor    or 3. other    
  
(9) Would you offer the customer any advice for the problem mentioned in question 
8?                                Yes             No               
 
 
(10) If yes, what advice would you give? 
        1. Oral hygiene advice 
        2. Take a multivitamin 
        3. Advice regarding application of medicine 
        4.Other: __________________________________________________________ 
 
(11) If a customer presents with oral thrush (a fungal infection in the mouth), would   
you  
a)  1. Take a history (i.e. ask more questions about it) 
b)  2. Recommend a treatment? 
c)  3. Refer the patient to a doctor/dentist? 
d)  4. All of the above? 
e)  5. a & b 
f)     6. a & c 
g)  7. b & c 
h)  8. None of the above?  
i)    9. Other, please specify       
 
(11a) What questions would you ask? 
       1. How long has it been there? 
       2. Have you taken antibiotics recently? 
       3. Are you taking any other medication? 
              4. Other ______________________________________________________ 
 
(11b)What treatment would you recommend? 
               1. Nystatin 
  2. Daktarin 
  3. Antibiotics 
  4. Probiotics 
  5. Mycostatin 
               6. Other:  
  
(12c) Who would you refer the patient to?  
          1. dentist     or 2.doctor    or 3. other    
 
(13) Would you offer the customer any advice for the problem mentioned in 
question 10?           1. Yes            2. No        
             
(14) If yes, what advice would you give? 
1. Advice regarding application of medicine 
2. To improve oral hygiene 
         3. Take a multivitamin 
         4. If there’s no change then see a doctor/ dentist 
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   5.Other: ______________________________________________________ 
 
  
(15) If a customer complains that he/she has a mouth ulcer for more than four 
weeks that hasn’t healed despite topical medication, would you 
a)  1. Take a history (i.e. ask more questions about it) 
b)  2. Recommend a treatment? 
c)  3. Refer the patient to a doctor/dentist? 
d)  4. All of the above? 
e)  5. a & b 
f)     6. a & c 
g)  7. b & c 
h)  8. None of the above?  
i)     9. Other, please specify        
 
(15a) What questions would you ask? 
 1. How long has it been there? 
 2. What medication did you use for the ulcer? 
 3. Do you smoke and/ or drink alcohol? 
 4. Is it painful? 
      5. Other _________________________________________________ 
 
(15b) What treatment would you recommend? 
1. Kenalog in orabase 
2. Pyralvex 
3. Dynexan 
4. Chlorhexidine 
5. Other __________________________________________________ 
 
(15c) Who would you refer the patient to: 1.dentist    2.doctor   3.other    
 
(16) Would you offer the customer any advice for the problem mentioned in 
question 12?               1. Yes            1.  No               
 
(17) If yes, what advice would you give? 
   1. Basic oral hygiene advice 
 2. Seek medical attention ASAP 
 3. Take a multivitamin 
 4.Other____________________________________________________ 
 
18) If a customer complains of a ‘mouth sore’ would you  
1. Take a history (i.e. ask more questions about it) 
2. Recommend a treatment? 
3. Refer the patient to a doctor/dentist? 
4. All of the above? 
5. a & b 
6. a & c 
7. b & c 
8. None of the above?  
9. Other, please specify        
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 (18a) What questions would you ask? 
             1. How long has it been there? 
        2. Is it a recurring problem? 
        3. Medication history 
            4. Other please specify       
 
(18b) What treatment would you recommend? 
               1. Pyrelvex 
          2. Dequadin 
          3. Depends on the cause 
               4. Other: _______________________________________________ 
 
(18c) Who would you refer the patient to: 
           1. dentist     or 2. doctor    or 3. other    
 
(19) Would you offer the customer any advice for the problem mentioned in 
question   14?                1. Yes             2. No               
 
(20) If yes, what advice would you give? 
   1. Basic oral hygiene advice 
   2. Advice regarding application of medicine 
   3. Depends on the cause 
   4. Other _________________________________________________ 
 
 (21) Can ulcers in the mouth be indicative of underlying disease?  
                                    1.  Yes             2. No                   3. I don’t know    
 
 (22) If you answered yes to question 16, please list the disease/s below: 
         1. STD’s   2. Vitamin and mineral deficiency 
             3. Immune deficiency             4. Other: 
 
 i                           ii      
 
iii                          iv      
 
 (23) Can thrush in the mouth be indicative of underlying disease/s?  
            1. Yes             2. No             3. I don’t know    
 
(24) If you answered yes to question 17, please list the disease/s below: 
        1. Immune deficiency     2. Antibiotic use 
        3. Vitamin and mineral deficiency   4. Other:  
 
 i                           ii      
iii                          iv      
 
 
THANK YOU VERY MUCH FOR YOUR PARTICIPATION! 
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APPENDIX 4 
 
FREQUENCY OF ORAL PROBLEMS STRATIFIED BY METROPOLITAN 
LOCATION AND SOCIO-ECONOMIC STATUS 
 
Mouth  
problem 
Metropolitan location Socio-Economic Status 
 Metro 
% 
Non – 
metro
    % 
RR (CI) TEST High
% 
Low 
% 
RR (CI) TEST
Ulcers 58 53     1.1 
(0.8-1.5) 
χ2=0.3 
p=0.6 
49.1 61.9 0.8 
(0.6-1.1) 
  χ2=1.9
p=0.2
Thrush 40 58 0.7 
(0.5-1.0)
χ2=4.0 
p=0.04 
61.4 38.1 1.6 
(1.1-2.4) 
χ2=6.5
p=0.01
Toothache 43.3 23.3 1.9 
(1.1-3.2)
χ2=5.4 
p=0.02 
29.8 36.5 0.8 
(0.5-1.4) 
 χ2=0.6
p=0.4
Bleeding  
gums 
20 18.3 1.1 
(0.5-2.3)
χ2=0.05
p=0.8 
15.8 22.2 0.7 
(0.3-1.5) 
χ2=0.8
p=0.4
Abscess 13.3 21.7 0.6 
(0.3-1.4)
χ2=1.4 
p=0.2 
24.6 11.1 2.2 
(0.9-5.1) 
χ2=3.7
p=0.05
Other 20 11.7 1.7 
(0.7-4.05)
χ2=1.56
p=0.2 
10.5 20.6 0.5 
(0.2-1.25)
χ2=2.3
p=0.1
Sore throat 16.7 13.3 1.3 
(0.5-2.9)
χ2=0.3 
p=0.6 
10.5 19 0.5 
(0.2-1.4) 
χ2=1.7
p=0.2
Herpes 11.7 13.3 0.9 
(0.3-2.3)
χ2=0.07
p=0.8 
7 17.5 0.4 
(0.1-1.2) 
FE 
p=0.07
Mouth sore 3.3 16.7 0.2 
(0.04-0.87
FE 
p=0.01 
14.0 6.3 2.2 
(0.7-6.9) 
FE 
p=0.1
Loose  
dentures 
6.7 8.3 0.8 
(0.2-2.8)
FE 
p=0.5 
3.2 11.1 0.3 
(0.06-1.5)
FE 
p=0.1
Gum  
problems 
5 6.7 0.7 
(0.2-3.2)
FE 
p=0.5 
3.5 7.9 0.4 
(0.1-2.1) 
FE 
p=0.3
Pain in  
mouth 
3.3 5 0.7 
(0.1-3.8)
FE 
p=0.5 
3.5 4.8 0.7 
(0.1-4.2) 
FE 
p=0.5
Tongue  
problems 
3.3 5 0.7 
(0.1-3.8)
FE 
p=0.5 
7 1.6 4.4 
(0.5-38.4)
FE 
p=0.1
 
χ2= Chi Square test 
FE = Fisher Exact test 
RR= Relative Risk 
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APPENDIX 5 
QUESTIONS FOR HISTORY-TAKING 
 
CATEGORY LIST OF QUESTIONS IN EACH 
CATEGORY 
Past medical 
history 
i. Allergies and reactions to drugs 
ii. Previous and current illnesses 
iii. Medicines were taken in the past 6 months 
iv. Current medication 
 
Social and 
professional 
information 
i. History of illnesses in the family 
ii. Hygiene (face and hair cleansing routine) 
iii. Head coverings, e.g. hats, caps, bandanas, 
etc. 
iv. Bedbugs or other biting insects 
 
History of the 
present illness 
i. Description of the problem 
ii. Chronology of symptoms (abrupt or 
gradual onset,    intermittent, transient, how 
long has it been there, is it recurrent, etc). 
iii. Precipitating, aggravating and relieving 
factors 
  iv.   Accompanying symptoms, e.g. burns, 
itchiness,   pain,  etc) 
v.   Personal contacts presenting with similar 
lesions 
 
Lifestyle history i. Dietary questions, e.g. have you eaten hard 
or  spicy  foods lately 
ii. Oral hygiene questions, for e.g., how often 
do you brush your teeth, do you floss, etc 
iii. Questions regarding smoking an alcohol   
consumption 
  iv.   Questions to ascertain if the patient is 
under stress 
 
 
 
 
 
 
 
 
